This is a Validated Antibody Database (VAD) review about human alpha synuclein, based on 168 published articles (read how Labome selects the articles), using alpha synuclein antibody in all methods. It is aimed to help Labome visitors find the most suited alpha synuclein antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
alpha synuclein synonym: NACP; PARK1; PARK4; PD1

Knockout validation
Abcam
domestic rabbit monoclonal (EP1536Y)
  • immunohistochemistry knockout validation; human; loading ...; fig 2a
  • immunocytochemistry; human; loading ...; fig 6d
Abcam alpha synuclein antibody (Abcam, ab51253) was used in immunohistochemistry knockout validation on human samples (fig 2a) and in immunocytochemistry on human samples (fig 6d). Acta Neuropathol (2021) ncbi
Abcam
domestic rabbit monoclonal (EP1536Y)
  • immunohistochemistry - frozen section; rat; loading ...; fig 6a
  • western blot knockout validation; mouse; loading ...; fig 7
  • immunohistochemistry - frozen section; mouse; loading ...; fig 6a
Abcam alpha synuclein antibody (Abcam, ab51253) was used in immunohistochemistry - frozen section on rat samples (fig 6a), in western blot knockout validation on mouse samples (fig 7) and in immunohistochemistry - frozen section on mouse samples (fig 6a). J Comp Neurol (2018) ncbi
Abcam
mouse monoclonal (4D6)
  • immunohistochemistry knockout validation; mouse; 1:800; fig 1
In order to characterize mice that over express murine alpha-Synuclein, Abcam alpha synuclein antibody (Abcam, 4D6) was used in immunohistochemistry knockout validation on mouse samples at 1:800 (fig 1). PLoS ONE (2011) ncbi
Invitrogen
mouse monoclonal (Syn 211)
  • western blot knockout validation; human; 1:1000; loading ...; fig 6a
  • immunocytochemistry; human; 1:400; loading ...; fig 5b, 8
Invitrogen alpha synuclein antibody (Thermo Fisher, MS-1572) was used in western blot knockout validation on human samples at 1:1000 (fig 6a) and in immunocytochemistry on human samples at 1:400 (fig 5b, 8). Neurobiol Aging (2018) ncbi
BD Biosciences
mouse monoclonal (42/?-Synuclein)
  • western blot knockout validation; human; 1:1000; loading ...; fig 2a
  • immunohistochemistry - paraffin section; human; 1:500; fig 6a
BD Biosciences alpha synuclein antibody (BD Biosciences, 610786) was used in western blot knockout validation on human samples at 1:1000 (fig 2a) and in immunohistochemistry - paraffin section on human samples at 1:500 (fig 6a). Sci Rep (2021) ncbi
BD Biosciences
mouse monoclonal (42/?-Synuclein)
  • immunocytochemistry knockout validation; human; 1:500; loading ...; fig 2a
  • western blot knockout validation; human; loading ...; fig 2b1
BD Biosciences alpha synuclein antibody (BD Biosciences, 610786) was used in immunocytochemistry knockout validation on human samples at 1:500 (fig 2a) and in western blot knockout validation on human samples (fig 2b1). Sci Rep (2019) ncbi
BD Biosciences
mouse monoclonal (42/?-Synuclein)
  • western blot knockout validation; mouse; loading ...; fig 7
BD Biosciences alpha synuclein antibody (BD Biosciences, 610786) was used in western blot knockout validation on mouse samples (fig 7). J Comp Neurol (2018) ncbi
BD Biosciences
mouse monoclonal (42/?-Synuclein)
  • western blot knockout validation; mouse; 1:300; fig 2c
BD Biosciences alpha synuclein antibody (BD, 610786) was used in western blot knockout validation on mouse samples at 1:300 (fig 2c). J Neuroinflammation (2016) ncbi
BD Biosciences
mouse monoclonal (42/?-Synuclein)
  • western blot; human; 1:2000; fig 5
  • immunohistochemistry knockout validation; mouse; fig 1
  • western blot knockout validation; mouse; 1:2000; fig 2
In order to characterize modulation of retinal iron homeostasis by facilitating the update of transferrin-bound iron by alpha-synuclein which may be a visual manifestation of Parkinson's disease, BD Biosciences alpha synuclein antibody (BD transduction, 610786) was used in western blot on human samples at 1:2000 (fig 5), in immunohistochemistry knockout validation on mouse samples (fig 1) and in western blot knockout validation on mouse samples at 1:2000 (fig 2). Free Radic Biol Med (2016) ncbi
BD Biosciences
mouse monoclonal (42/?-Synuclein)
  • western blot knockout validation; mouse; 1:1000; fig 3
BD Biosciences alpha synuclein antibody (BD Biosciences, 610786) was used in western blot knockout validation on mouse samples at 1:1000 (fig 3). Sci Rep (2015) ncbi
Abcam
mouse monoclonal (4D6)
  • western blot; mouse; 1:3000; loading ...; fig 4g, 4h
  • western blot; human; 1:3000; loading ...; fig 4c
Abcam alpha synuclein antibody (Abcam, ab1903) was used in western blot on mouse samples at 1:3000 (fig 4g, 4h) and in western blot on human samples at 1:3000 (fig 4c). NPJ Parkinsons Dis (2022) ncbi
domestic rabbit monoclonal (EP1536Y)
  • other; human; 1:1000; loading ...; fig 3a
Abcam alpha synuclein antibody (Abcam, ab51253) was used in other on human samples at 1:1000 (fig 3a). Biomolecules (2022) ncbi
mouse monoclonal (LB 509)
  • other; human; 1:1000; loading ...; fig 3a
Abcam alpha synuclein antibody (Abcam, ab27766) was used in other on human samples at 1:1000 (fig 3a). Biomolecules (2022) ncbi
domestic rabbit monoclonal (MJFR1)
  • immunohistochemistry; African green monkey; 1:2000; fig 1e, 1f
Abcam alpha synuclein antibody (Abcam, ab138501) was used in immunohistochemistry on African green monkey samples at 1:2000 (fig 1e, 1f). Int J Mol Sci (2022) ncbi
domestic rabbit monoclonal (EP1536Y)
  • western blot; mouse; loading ...; fig 2g
Abcam alpha synuclein antibody (abcam, Ab51253) was used in western blot on mouse samples (fig 2g). Int J Mol Sci (2022) ncbi
mouse monoclonal (4D6)
  • immunohistochemistry - paraffin section; African green monkey; loading ...; fig 2h
Abcam alpha synuclein antibody (Abcam, 4D6) was used in immunohistochemistry - paraffin section on African green monkey samples (fig 2h). Pathogens (2022) ncbi
domestic rabbit monoclonal (EP1536Y)
  • immunohistochemistry; human; 1:4000; loading ...; fig 5e
  • western blot; human; 1:500; loading ...; fig 4c
Abcam alpha synuclein antibody (Abcam, 51253) was used in immunohistochemistry on human samples at 1:4000 (fig 5e) and in western blot on human samples at 1:500 (fig 4c). Neurotherapeutics (2022) ncbi
domestic rabbit monoclonal (MJF-R13 (8-8))
  • western blot; human; 1:500; fig 2f
Abcam alpha synuclein antibody (Abcam, 168,381) was used in western blot on human samples at 1:500 (fig 2f). Neurotherapeutics (2022) ncbi
domestic rabbit monoclonal (EP1536Y)
  • immunohistochemistry - frozen section; human; 1:1000; loading ...; fig s11e
Abcam alpha synuclein antibody (Abcam, ab51253) was used in immunohistochemistry - frozen section on human samples at 1:1000 (fig s11e). ACS Chem Neurosci (2022) ncbi
domestic rabbit monoclonal (EP1536Y)
  • immunohistochemistry - paraffin section; human; 5 ug/ml; loading ...; fig 8c
  • western blot; human; loading ...; fig s1c, s3a, s7
  • immunohistochemistry - free floating section; mouse; loading ...; fig 7a
Abcam alpha synuclein antibody (Abcam, ab51253) was used in immunohistochemistry - paraffin section on human samples at 5 ug/ml (fig 8c), in western blot on human samples (fig s1c, s3a, s7) and in immunohistochemistry - free floating section on mouse samples (fig 7a). Proc Natl Acad Sci U S A (2022) ncbi
domestic rabbit monoclonal (EP1536Y)
  • immunohistochemistry - free floating section; mouse; 1:1000; loading ...; fig 3c
Abcam alpha synuclein antibody (Abcam, ab51253) was used in immunohistochemistry - free floating section on mouse samples at 1:1000 (fig 3c). Mol Ther Nucleic Acids (2022) ncbi
domestic rabbit monoclonal (MJFR1)
  • western blot; mouse; 1:2000; loading ...
Abcam alpha synuclein antibody (Abcam, ab138501) was used in western blot on mouse samples at 1:2000. Redox Biol (2021) ncbi
mouse monoclonal (syn211)
  • immunocytochemistry; human; fig 2b
  • western blot; human; 1:2000; fig 1b
Abcam alpha synuclein antibody (Abcam, ab80627) was used in immunocytochemistry on human samples (fig 2b) and in western blot on human samples at 1:2000 (fig 1b). Front Cell Dev Biol (2021) ncbi
domestic rabbit monoclonal (EP1536Y)
  • immunohistochemistry; mouse; 1:300; loading ...; fig 4o
Abcam alpha synuclein antibody (Abcam, Ab51253) was used in immunohistochemistry on mouse samples at 1:300 (fig 4o). Ann Neurol (2021) ncbi
domestic rabbit monoclonal (MJFR-14-6-4-2)
  • immunohistochemistry; human; 1:300; loading ...; fig 1i
Abcam alpha synuclein antibody (Abcam, ab209538) was used in immunohistochemistry on human samples at 1:300 (fig 1i). Acta Neuropathol (2021) ncbi
mouse monoclonal (P-syn/81A)
  • immunohistochemistry - free floating section; mouse; 1:2000; loading ...; fig 7d
Abcam alpha synuclein antibody (Abcam, ab184674) was used in immunohistochemistry - free floating section on mouse samples at 1:2000 (fig 7d). Neurobiol Dis (2021) ncbi
mouse monoclonal (syn211)
  • immunocytochemistry; human; 1:500; fig 1c
Abcam alpha synuclein antibody (Abcam, AB80627) was used in immunocytochemistry on human samples at 1:500 (fig 1c). NPJ Parkinsons Dis (2021) ncbi
mouse monoclonal (LB 509)
  • western blot; human; fig s9b
Abcam alpha synuclein antibody (Abcam, ab27766) was used in western blot on human samples (fig s9b). Nat Commun (2021) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; fig 3b
Abcam alpha synuclein antibody (Abcam, ab59264) was used in western blot on mouse samples at 1:1000 (fig 3b). Aging (Albany NY) (2021) ncbi
domestic rabbit monoclonal (MJFR1)
  • immunocytochemistry; human; 1:1000; fig e4a
  • ELISA; human; 1 ug/ml; fig 3b
  • western blot; human; 1:1000; loading ...; fig 3e
Abcam alpha synuclein antibody (Abcam, ab138501) was used in immunocytochemistry on human samples at 1:1000 (fig e4a), in ELISA on human samples at 1 ug/ml (fig 3b) and in western blot on human samples at 1:1000 (fig 3e). EMBO Mol Med (2021) ncbi
mouse monoclonal (P-syn/81A)
  • immunocytochemistry; human; 1:500; fig 4a
Abcam alpha synuclein antibody (Abcam, ab184674) was used in immunocytochemistry on human samples at 1:500 (fig 4a). EMBO Mol Med (2021) ncbi
domestic rabbit monoclonal (EP1536Y)
  • immunocytochemistry; human; 1:500; fig 4b
  • immunohistochemistry - frozen section; mouse; 1:1000; loading ...; fig 5b
  • immunohistochemistry; mouse; 1:1000; fig 5c
Abcam alpha synuclein antibody (Abcam, ab51253) was used in immunocytochemistry on human samples at 1:500 (fig 4b), in immunohistochemistry - frozen section on mouse samples at 1:1000 (fig 5b) and in immunohistochemistry on mouse samples at 1:1000 (fig 5c). EMBO Mol Med (2021) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:500; loading ...; fig 5a, 5b, 5c, 5d
Abcam alpha synuclein antibody (Abcam, ab-59264) was used in western blot on mouse samples at 1:500 (fig 5a, 5b, 5c, 5d). Aging Dis (2021) ncbi
domestic rabbit monoclonal (EP1536Y)
  • immunohistochemistry - free floating section; mouse; 1:10,000; loading ...; fig 3a, 4c
  • immunocytochemistry; human; 1:1000; loading ...; fig s2a
Abcam alpha synuclein antibody (Abcam, ab51253) was used in immunohistochemistry - free floating section on mouse samples at 1:10,000 (fig 3a, 4c) and in immunocytochemistry on human samples at 1:1000 (fig s2a). Transl Neurodegener (2021) ncbi
domestic rabbit monoclonal (EP1536Y)
  • immunohistochemistry; mouse; 1:600; loading ...; fig 2c
  • western blot; mouse; 1:1000; loading ...; fig 2a
Abcam alpha synuclein antibody (Abcam, 51253) was used in immunohistochemistry on mouse samples at 1:600 (fig 2c) and in western blot on mouse samples at 1:1000 (fig 2a). J Parkinsons Dis (2021) ncbi
domestic rabbit monoclonal (EP1536Y)
  • immunohistochemistry; human; 1:500; fig s3e
  • western blot; human; 1:2500; loading ...; fig s3d
Abcam alpha synuclein antibody (Abcam, ab51253) was used in immunohistochemistry on human samples at 1:500 (fig s3e) and in western blot on human samples at 1:2500 (fig s3d). Nat Commun (2021) ncbi
domestic rabbit monoclonal (EP1536Y)
  • immunohistochemistry - frozen section; human; 1:500; loading ...
Abcam alpha synuclein antibody (Abcam, ab-51253) was used in immunohistochemistry - frozen section on human samples at 1:500. Neurology (2021) ncbi
mouse monoclonal (4D6)
  • immunohistochemistry; mouse; fig 3a
  • western blot; mouse; loading ...
Abcam alpha synuclein antibody (Abcam, Ab1903) was used in immunohistochemistry on mouse samples (fig 3a) and in western blot on mouse samples . Aging Cell (2021) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; fig 2
Abcam alpha synuclein antibody (Abcam, Ab59264) was used in immunohistochemistry on mouse samples (fig 2). Acta Neuropathol Commun (2021) ncbi
domestic rabbit monoclonal (MJFR-14-6-4-2)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; fig 2f
  • immunohistochemistry - frozen section; mouse; 1:200; loading ...; fig 5a
Abcam alpha synuclein antibody (Abcam, ab209538) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 2f) and in immunohistochemistry - frozen section on mouse samples at 1:200 (fig 5a). Acta Neuropathol Commun (2021) ncbi
domestic rabbit monoclonal (EP1536Y)
  • immunohistochemistry knockout validation; human; loading ...; fig 2a
  • immunocytochemistry; human; loading ...; fig 6d
Abcam alpha synuclein antibody (Abcam, ab51253) was used in immunohistochemistry knockout validation on human samples (fig 2a) and in immunocytochemistry on human samples (fig 6d). Acta Neuropathol (2021) ncbi
domestic rabbit monoclonal (MJFR-14-6-4-2)
  • western blot; mouse; 1:5000; loading ...; fig 3d, 4h
Abcam alpha synuclein antibody (Abcam, ab209538) was used in western blot on mouse samples at 1:5000 (fig 3d, 4h). Cell Death Dis (2021) ncbi
domestic rabbit monoclonal (EP1536Y)
  • immunohistochemistry - free floating section; rat; 1:500; loading ...; fig 3e
Abcam alpha synuclein antibody (Abcam, ab51253) was used in immunohistochemistry - free floating section on rat samples at 1:500 (fig 3e). Neurobiol Dis (2021) ncbi
mouse monoclonal (4D6)
  • proximity ligation assay; mouse; 1:2000; loading ...; fig 4d
Abcam alpha synuclein antibody (Abcam, ab1903) was used in proximity ligation assay on mouse samples at 1:2000 (fig 4d). J Neurosci (2021) ncbi
domestic rabbit monoclonal (EP1536Y)
  • immunohistochemistry; mouse; 1:500; loading ...; fig 4c
  • western blot; mouse; loading ...; fig 4a
Abcam alpha synuclein antibody (Abcam, ab51253) was used in immunohistochemistry on mouse samples at 1:500 (fig 4c) and in western blot on mouse samples (fig 4a). Cell Death Dis (2020) ncbi
mouse monoclonal (4D6)
  • proximity ligation assay; human; 1:2000; loading ...; fig s2a, s3a, s4c
Abcam alpha synuclein antibody (Abcam, ab1903) was used in proximity ligation assay on human samples at 1:2000 (fig s2a, s3a, s4c). Nat Commun (2020) ncbi
domestic rabbit monoclonal (MJFR1)
  • western blot; mouse; 1:1000; loading ...; fig 5h
Abcam alpha synuclein antibody (Abcam, MJFR1) was used in western blot on mouse samples at 1:1000 (fig 5h). Nat Commun (2020) ncbi
domestic rabbit monoclonal (EP1646Y)
  • immunohistochemistry; mouse; 1:1000; loading ...; fig 2a
Abcam alpha synuclein antibody (Abcam, ab51252) was used in immunohistochemistry on mouse samples at 1:1000 (fig 2a). elife (2020) ncbi
mouse monoclonal (LB 509)
  • western blot; mouse; 1:800; loading ...; fig 2c
Abcam alpha synuclein antibody (Abcam, ab27766) was used in western blot on mouse samples at 1:800 (fig 2c). Brain Pathol (2020) ncbi
domestic rabbit monoclonal (EP1536Y)
  • immunohistochemistry; mouse; 1:400; loading ...; fig 2h
Abcam alpha synuclein antibody (Abcam, ab51253) was used in immunohistochemistry on mouse samples at 1:400 (fig 2h). Brain Pathol (2020) ncbi
mouse monoclonal (LB 509)
  • immunohistochemistry; human; 1:2000; loading ...; fig s2
Abcam alpha synuclein antibody (Abcam, ab27766) was used in immunohistochemistry on human samples at 1:2000 (fig s2). JCI Insight (2020) ncbi
domestic rabbit monoclonal (EP1536Y)
  • immunohistochemistry - paraffin section; mouse; 1:800; loading ...; fig 2k
Abcam alpha synuclein antibody (Abcam (, ab51253) was used in immunohistochemistry - paraffin section on mouse samples at 1:800 (fig 2k). Nat Commun (2020) ncbi
domestic rabbit monoclonal (EP1536Y)
  • western blot; mouse; 1:1000; loading ...; fig 1s2e
Abcam alpha synuclein antibody (AbCam, Ab51253) was used in western blot on mouse samples at 1:1000 (fig 1s2e). elife (2020) ncbi
domestic rabbit monoclonal (MJFR-14-6-4-2)
  • immunocytochemistry; mouse; 1:200; loading ...; fig 1, 3b, 4b, 5c, 6
Abcam alpha synuclein antibody (Abcam, Cambridge, UK), MJFR-14-6-4-2) was used in immunocytochemistry on mouse samples at 1:200 (fig 1, 3b, 4b, 5c, 6). Molecules (2020) ncbi
domestic rabbit monoclonal (EP1536Y)
  • immunocytochemistry; mouse; 1:200; loading ...; fig 4b
Abcam alpha synuclein antibody (Abcam, Berlin, Germany, ab51253) was used in immunocytochemistry on mouse samples at 1:200 (fig 4b). Molecules (2020) ncbi
domestic rabbit monoclonal (EP1536Y)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 4a
Abcam alpha synuclein antibody (Abcam, EP1536Y) was used in immunohistochemistry - paraffin section on mouse samples (fig 4a). Acta Neuropathol (2020) ncbi
domestic rabbit monoclonal (MJFR1)
  • immunohistochemistry - paraffin section; rhesus macaque; 1:200; loading ...; fig s6a
Abcam alpha synuclein antibody (Abcam, AB138501) was used in immunohistochemistry - paraffin section on rhesus macaque samples at 1:200 (fig s6a). PLoS ONE (2020) ncbi
domestic rabbit monoclonal (MJFR-14-6-4-2)
  • immunohistochemistry; mouse; 1:25,000; fig 1f
Abcam alpha synuclein antibody (Abcam, ab209538) was used in immunohistochemistry on mouse samples at 1:25,000 (fig 1f). Acta Neuropathol Commun (2019) ncbi
domestic rabbit monoclonal (MJFR1)
Abcam alpha synuclein antibody (Abcam, ab138501) was used . Acta Neuropathol Commun (2019) ncbi
mouse monoclonal (LB 509)
  • immunoprecipitation; human; 1:500; loading ...; fig e7e
  • immunocytochemistry; human; 1:1000; loading ...; fig 3a
Abcam alpha synuclein antibody (Abcam, ab27766) was used in immunoprecipitation on human samples at 1:500 (fig e7e) and in immunocytochemistry on human samples at 1:1000 (fig 3a). Nature (2020) ncbi
domestic rabbit monoclonal (MJFR1)
  • western blot; human; loading ...; fig e7a
Abcam alpha synuclein antibody (ABCAM, ab138501) was used in western blot on human samples (fig e7a). Nature (2020) ncbi
domestic rabbit monoclonal (EP1536Y)
  • western blot; mouse; 1:5000; loading ...; fig 5f
Abcam alpha synuclein antibody (Abcam, 51253) was used in western blot on mouse samples at 1:5000 (fig 5f). Acta Neuropathol (2019) ncbi
domestic rabbit monoclonal (MJF-R13 (8-8))
  • western blot; mouse; 1:1000; loading ...; fig 7g
Abcam alpha synuclein antibody (Abcam, ab168381) was used in western blot on mouse samples at 1:1000 (fig 7g). Acta Neuropathol (2019) ncbi
mouse monoclonal (LB 509)
  • western blot; mouse; fig 5d
  • western blot; human; 1:1000; fig 5c
Abcam alpha synuclein antibody (Abcam, ab27766) was used in western blot on mouse samples (fig 5d) and in western blot on human samples at 1:1000 (fig 5c). Acta Neuropathol (2019) ncbi
domestic rabbit monoclonal (EP1536Y)
  • immunohistochemistry - free floating section; human; 1:100; loading ...; fig 4a
Abcam alpha synuclein antibody (Abcam, ab51253) was used in immunohistochemistry - free floating section on human samples at 1:100 (fig 4a). elife (2019) ncbi
domestic rabbit monoclonal (EP1536Y)
  • western blot; mouse; 1:1000; loading ...; fig 3a, 3d
Abcam alpha synuclein antibody (Abcam, Ab51253) was used in western blot on mouse samples at 1:1000 (fig 3a, 3d). Aging Cell (2019) ncbi
mouse monoclonal (4D6)
  • western blot; mouse; 1:1000; loading ...; fig 3a, 3d
Abcam alpha synuclein antibody (Abcam, Ab1903) was used in western blot on mouse samples at 1:1000 (fig 3a, 3d). Aging Cell (2019) ncbi
mouse monoclonal (4D6)
  • immunocytochemistry; human; loading ...; fig 4a
  • western blot; human; loading ...; fig 3a
Abcam alpha synuclein antibody (Abcam, 4D6) was used in immunocytochemistry on human samples (fig 4a) and in western blot on human samples (fig 3a). Sci Rep (2019) ncbi
domestic rabbit monoclonal (MJFR1)
  • western blot; human; 1:4000; loading ...; fig 6a
Abcam alpha synuclein antibody (Abcam, MJFR1) was used in western blot on human samples at 1:4000 (fig 6a). Biomolecules (2018) ncbi
domestic rabbit monoclonal (MJFR-14-6-4-2)
  • immunocytochemistry; rat; 1:100; loading ...; fig 3b
Abcam alpha synuclein antibody (Abcam, ab209538) was used in immunocytochemistry on rat samples at 1:100 (fig 3b). Nat Commun (2018) ncbi
domestic rabbit monoclonal (EP1536Y)
  • immunohistochemistry - frozen section; rat; loading ...; fig 6a
  • western blot knockout validation; mouse; loading ...; fig 7
  • immunohistochemistry - frozen section; mouse; loading ...; fig 6a
Abcam alpha synuclein antibody (Abcam, ab51253) was used in immunohistochemistry - frozen section on rat samples (fig 6a), in western blot knockout validation on mouse samples (fig 7) and in immunohistochemistry - frozen section on mouse samples (fig 6a). J Comp Neurol (2018) ncbi
domestic rabbit monoclonal (MJFR-14-6-4-2)
  • other; rat; loading ...; fig 3d
Abcam alpha synuclein antibody (Abcam, ab209538) was used in other on rat samples (fig 3d). Neurobiol Aging (2018) ncbi
mouse monoclonal (4D6)
  • immunohistochemistry; mouse; 1:250; loading ...; fig 5
  • western blot; mouse; 1:200; loading ...; fig s3a
In order to research the role of arginylation in the function of alpha synuclein, Abcam alpha synuclein antibody (Abcam, 4D6) was used in immunohistochemistry on mouse samples at 1:250 (fig 5) and in western blot on mouse samples at 1:200 (fig s3a). Sci Rep (2017) ncbi
mouse monoclonal (LB 509)
  • immunohistochemistry - paraffin section; mouse; 1:500; loading ...; fig 1d
Abcam alpha synuclein antibody (Abcam, ab27766) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig 1d). Dis Model Mech (2017) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - free floating section; mouse; 1:250; loading ...; fig 8a
  • western blot; mouse; 1:1000; loading ...; fig 7a
In order to elucidate the effects of mutations in leucine-rich repeat kinase 2 on nigro0striatal dopamine neurons, Abcam alpha synuclein antibody (Abcam, ab52168) was used in immunohistochemistry - free floating section on mouse samples at 1:250 (fig 8a) and in western blot on mouse samples at 1:1000 (fig 7a). Acta Neuropathol Commun (2017) ncbi
domestic rabbit monoclonal (EP1536Y)
  • western blot; mouse; 1:1000; loading ...; fig 7a
In order to elucidate the effects of mutations in leucine-rich repeat kinase 2 on nigro0striatal dopamine neurons, Abcam alpha synuclein antibody (Abcam, ab51253) was used in western blot on mouse samples at 1:1000 (fig 7a). Acta Neuropathol Commun (2017) ncbi
domestic rabbit monoclonal (EP1536Y)
  • immunohistochemistry; human; 1:1000; loading ...; tbl 1
In order to describe a dichotomy between graft structure and clinical function in a patient dying 16 years following fetal nigral grafting, Abcam alpha synuclein antibody (Abcam, ab51253) was used in immunohistochemistry on human samples at 1:1000 (tbl 1). Ann Neurol (2017) ncbi
mouse monoclonal (LB 509)
  • western blot; human; 1:1000; loading ...; fig 3a
In order to demonstrate the protective effects of an oligomer-specific single-chain variable fragment antibody in Parkinson's disease and Huntington's disease mouse models, Abcam alpha synuclein antibody (Abcam, ab27766) was used in western blot on human samples at 1:1000 (fig 3a). Sci Rep (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:50; loading ...; fig 4a
In order to demonstrate the protective effects of an oligomer-specific single-chain variable fragment antibody in Parkinson's disease and Huntington's disease mouse models, Abcam alpha synuclein antibody (Abcam, ab59264) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 4a). Sci Rep (2016) ncbi
mouse monoclonal (4D6)
  • western blot; human; 1:1000; loading ...; fig 2a
In order to test if prolyl oligopeptidase inhibition overcomes the alpha-synuclein aggregation and toxicity induced by lactacystin, Abcam alpha synuclein antibody (AbCam, ab1903) was used in western blot on human samples at 1:1000 (fig 2a). Neurosci Lett (2017) ncbi
mouse monoclonal (LB 509)
  • immunocytochemistry; rat; fig 7
  • immunocytochemistry; human; fig 6
Abcam alpha synuclein antibody (abcam, 27766) was used in immunocytochemistry on rat samples (fig 7) and in immunocytochemistry on human samples (fig 6). J Cell Biol (2016) ncbi
domestic rabbit monoclonal (EP1536Y)
  • western blot; mouse; 1:1000; loading ...; fig s4b
In order to demonstrate that sustained Lmx1a and Lmx1b expression is needed for the survival of adult midbrain dopaminergic neurons, Abcam alpha synuclein antibody (Abcam, ab51253) was used in western blot on mouse samples at 1:1000 (fig s4b). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (LB 509)
  • immunohistochemistry - frozen section; domestic rabbit; fig s1
In order to characterize the role of endolysosomes in skeletal muscle pathology observed in a model of Alzheimer's disease with a cholesterol-fed rabbit, Abcam alpha synuclein antibody (Abcam, ab27766) was used in immunohistochemistry - frozen section on domestic rabbit samples (fig s1). Front Aging Neurosci (2016) ncbi
domestic rabbit monoclonal (EP1646Y)
  • immunocytochemistry; rat; 1:500; loading ...; fig 2c
  • western blot; rat; 1:1000; loading ...; fig 2b
  • immunocytochemistry; human; 1:500; loading ...; fig 2c
  • western blot; human; 1:1000; loading ...; fig 2b
Abcam alpha synuclein antibody (Abcam, ab51252) was used in immunocytochemistry on rat samples at 1:500 (fig 2c), in western blot on rat samples at 1:1000 (fig 2b), in immunocytochemistry on human samples at 1:500 (fig 2c) and in western blot on human samples at 1:1000 (fig 2b). Nat Commun (2016) ncbi
mouse monoclonal (4D6)
  • western blot; mouse; 1:1000; loading ...; fig 2a
Abcam alpha synuclein antibody (Abcam, ab1903) was used in western blot on mouse samples at 1:1000 (fig 2a). Front Cell Neurosci (2015) ncbi
domestic rabbit monoclonal (EP1536Y)
  • immunohistochemistry - paraffin section; human; 1:1000; fig 3a
  • western blot; human; 1:4000; fig 1c
Abcam alpha synuclein antibody (Abcam, ab51253) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (fig 3a) and in western blot on human samples at 1:4000 (fig 1c). Proc Natl Acad Sci U S A (2015) ncbi
mouse monoclonal (4D6)
  • western blot; mouse; loading ...; fig 1b
Abcam alpha synuclein antibody (Abcam, ab1903) was used in western blot on mouse samples (fig 1b). Age (Dordr) (2015) ncbi
domestic rabbit monoclonal (EP1536Y)
  • immunocytochemistry; human; 1:200; fig 8
Abcam alpha synuclein antibody (Abcam, ab51253) was used in immunocytochemistry on human samples at 1:200 (fig 8). PLoS ONE (2015) ncbi
mouse monoclonal (LB 509)
  • immunohistochemistry; human; 1:500
In order to characterize the neuropathological features of dystonias, Abcam alpha synuclein antibody (Abcam, Ab27766) was used in immunohistochemistry on human samples at 1:500. Tremor Other Hyperkinet Mov (N Y) (2015) ncbi
mouse monoclonal (LB 509)
  • western blot; human; 1:5000; fig 4a
In order to discuss decontaminating medical devices of pathological amyloid-beta-, tau- and alpha-synuclein aggregates, Abcam alpha synuclein antibody (Abcam, ab27766) was used in western blot on human samples at 1:5000 (fig 4a). Acta Neuropathol Commun (2014) ncbi
domestic rabbit monoclonal (EP1536Y)
  • western blot; human; 1:2000
In order to discuss decontaminating medical devices of pathological amyloid-beta-, tau- and alpha-synuclein aggregates, Abcam alpha synuclein antibody (Abcam, ab51253) was used in western blot on human samples at 1:2000. Acta Neuropathol Commun (2014) ncbi
domestic rabbit monoclonal (EP1536Y)
  • flow cytometry; human; fig s6
Abcam alpha synuclein antibody (Abcam, ab51253) was used in flow cytometry on human samples (fig s6). Lab Invest (2014) ncbi
domestic rabbit monoclonal (EP1646Y)
  • western blot; human; 1:1000
Abcam alpha synuclein antibody (Abcam, ab51252) was used in western blot on human samples at 1:1000. Biochim Biophys Acta (2014) ncbi
domestic rabbit monoclonal (EP1646Y)
  • immunohistochemistry - free floating section; rat; 1:1000
Abcam alpha synuclein antibody (Abcam, ab51252) was used in immunohistochemistry - free floating section on rat samples at 1:1000. PLoS ONE (2013) ncbi
domestic rabbit monoclonal (EP1536Y)
  • immunohistochemistry - frozen section; human; 1:2000; fig 6
In order to study the time course of behavioral deficits and neuropathology in PDGF-beta human wild type alpha-synuclein transgenic mice, Abcam alpha synuclein antibody (Abcam, ab51253) was used in immunohistochemistry - frozen section on human samples at 1:2000 (fig 6). BMC Neurosci (2013) ncbi
mouse monoclonal (4D6)
  • immunohistochemistry - frozen section; mouse; 1:500; fig 5
  • immunohistochemistry - frozen section; human; 1:500; fig 5
In order to study the time course of behavioral deficits and neuropathology in PDGF-beta human wild type alpha-synuclein transgenic mice, Abcam alpha synuclein antibody (Abcam, ab1903) was used in immunohistochemistry - frozen section on mouse samples at 1:500 (fig 5) and in immunohistochemistry - frozen section on human samples at 1:500 (fig 5). BMC Neurosci (2013) ncbi
mouse monoclonal (4D6)
  • immunohistochemistry knockout validation; mouse; 1:800; fig 1
In order to characterize mice that over express murine alpha-Synuclein, Abcam alpha synuclein antibody (Abcam, 4D6) was used in immunohistochemistry knockout validation on mouse samples at 1:800 (fig 1). PLoS ONE (2011) ncbi
Invitrogen
mouse monoclonal (LB509)
  • immunohistochemistry - paraffin section; human; loading ...; fig 1
Invitrogen alpha synuclein antibody (Invitrogen, LB509) was used in immunohistochemistry - paraffin section on human samples (fig 1). J Parkinsons Dis (2022) ncbi
mouse monoclonal (Syn 211)
  • western blot; human; loading ...; fig 5c
Invitrogen alpha synuclein antibody (Invitrogen, AHB0261) was used in western blot on human samples (fig 5c). Front Cell Dev Biol (2021) ncbi
domestic rabbit recombinant (JB22-44)
  • western blot; human; 1:1000; loading ...; fig 1e
Invitrogen alpha synuclein antibody (Invitrogen, MA5-34,671) was used in western blot on human samples at 1:1000 (fig 1e). Acta Neuropathol (2021) ncbi
mouse monoclonal (Syn 211)
  • western blot; mouse; 1:1000; loading ...; fig 5a, 5b, 5c, 5d
Invitrogen alpha synuclein antibody (Life Technologies, AHB0261) was used in western blot on mouse samples at 1:1000 (fig 5a, 5b, 5c, 5d). Aging Dis (2021) ncbi
domestic rabbit recombinant (14H2L1)
  • immunocytochemistry; mouse; loading ...; fig 3a
  • immunocytochemistry; human; loading ...; fig 1f
Invitrogen alpha synuclein antibody (Thermo Scientific, 14H2L1) was used in immunocytochemistry on mouse samples (fig 3a) and in immunocytochemistry on human samples (fig 1f). Acta Neuropathol Commun (2021) ncbi
mouse monoclonal (Syn 211)
  • immunohistochemistry; human; 1:1000; loading ...; fig s2a
Invitrogen alpha synuclein antibody (Thermo, syn211) was used in immunohistochemistry on human samples at 1:1000 (fig s2a). Nat Commun (2020) ncbi
mouse monoclonal (Syn 211)
  • other; mouse; 1:500; loading ...; fig 4
Invitrogen alpha synuclein antibody (ThermoFisher Scientific, AHB0261) was used in other on mouse samples at 1:500 (fig 4). elife (2020) ncbi
domestic rabbit polyclonal
  • immunoprecipitation; mouse; loading ...; fig 4a
  • western blot; mouse; loading ...; fig 3a
Invitrogen alpha synuclein antibody (Thermo Fisher Scientific, PA5-17239) was used in immunoprecipitation on mouse samples (fig 4a) and in western blot on mouse samples (fig 3a). Free Radic Biol Med (2018) ncbi
mouse monoclonal (Syn 211)
  • western blot knockout validation; human; 1:1000; loading ...; fig 6a
  • immunocytochemistry; human; 1:400; loading ...; fig 5b, 8
Invitrogen alpha synuclein antibody (Thermo Fisher, MS-1572) was used in western blot knockout validation on human samples at 1:1000 (fig 6a) and in immunocytochemistry on human samples at 1:400 (fig 5b, 8). Neurobiol Aging (2018) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; mouse; 1:2000; loading ...; fig 1G
In order to assess the effects of autophagy induction on neurons with alpha-synuclein inclusions by a starvation and mTOR-independent autophagy induction mechanism, Invitrogen alpha synuclein antibody (Affinity Bioreagents, PA1-4686) was used in immunocytochemistry on mouse samples at 1:2000 (fig 1G). Redox Biol (2017) ncbi
mouse monoclonal (Syn 211)
  • immunohistochemistry - free floating section; African green monkey; 1:500; loading ...; fig 1A
In order to develop a non-human primate model of synucleinopathy using cynomolgus macaque, Invitrogen alpha synuclein antibody (Invitrogen, 32-8100) was used in immunohistochemistry - free floating section on African green monkey samples at 1:500 (fig 1A). PLoS ONE (2016) ncbi
mouse monoclonal (Syn 211)
  • western blot; human; 1:1000; fig 1b
In order to examine the dissociation of alpha-synuclein fibrils into monomers and assess their structural and dynamic properties, Invitrogen alpha synuclein antibody (Invitrogen, AHB0261) was used in western blot on human samples at 1:1000 (fig 1b). Sci Rep (2016) ncbi
mouse monoclonal (4B12)
In order to find antibodies that target the C-terminus of alpha-synuclein, Invitrogen alpha synuclein antibody (Thermo Fisher, MA1-90346) was used . Biophys Chem (2017) ncbi
mouse monoclonal (Syn 505)
  • immunohistochemistry; mouse; 1:1000; loading ...; fig 6j
In order to test if chronic stress enhances the progression of Parkinson's disease, Invitrogen alpha synuclein antibody (Thermo Fisher, 35-8300) was used in immunohistochemistry on mouse samples at 1:1000 (fig 6j). Exp Neurol (2016) ncbi
mouse monoclonal (Syn 211)
  • western blot; human; 1:1000; loading ...; fig 4b
In order to test if glucocerebrosidase activation reduces alpha-synuclein levels, Invitrogen alpha synuclein antibody (Thermo Fisher Scientific, syn211) was used in western blot on human samples at 1:1000 (fig 4b). J Neurosci (2016) ncbi
mouse monoclonal (Syn 211)
  • western blot; human; fig 3
In order to identify oligomeric alpha-synuclein, total alpha-synuclein, and SNCA variants in Parkinson's disease patients, Invitrogen alpha synuclein antibody (Invitrogen, AHB0261) was used in western blot on human samples (fig 3). Sci Rep (2016) ncbi
mouse monoclonal (Syn 211)
  • western blot; human; fig 2
In order to analyze the correlation between brain wave spectra in Parkinson's disease and cortical phosphorylated alpha-synuclein levels, Invitrogen alpha synuclein antibody (Life Tech, Syn 211) was used in western blot on human samples (fig 2). Mov Disord (2016) ncbi
mouse monoclonal (Syn 211)
  • immunohistochemistry; mouse; fig 1
In order to study a mouse model of Parkinson's disease for hypoestoxide to reduce neuroinflammation and alpha-synuclein accumulation, Invitrogen alpha synuclein antibody (Life Technologies, syn211) was used in immunohistochemistry on mouse samples (fig 1). J Neuroinflammation (2015) ncbi
mouse monoclonal (Syn 211)
  • immunocytochemistry; human
In order to study the effect of G2019S on neuronal subtypes, Invitrogen alpha synuclein antibody (Thermo, MA5-12272) was used in immunocytochemistry on human samples . Stem Cell Reports (2015) ncbi
domestic rabbit polyclonal
In order to assess the efficiency and potential safety of miRNA replacement therapy for Alzheimer's disease, Invitrogen alpha synuclein antibody (Thermo Fisher Scientific, PA1-18264) was used . Mol Ther Nucleic Acids (2015) ncbi
mouse monoclonal (Syn 211)
  • western blot; human; fig 4
In order to reduce alpha-synuclein accumulation in a mouse model of multiple system atrophy by using a brain-targeted, modified neurosin (kallikrein-6), Invitrogen alpha synuclein antibody (Life Technologies, SYN211) was used in western blot on human samples (fig 4). Mol Neurodegener (2015) ncbi
mouse monoclonal (Syn 211)
  • immunohistochemistry - paraffin section; human; 1:200
In order to present data from the first donated Lothian Birth Cohort of 1936 and compare it with other aged and diseased samples, Invitrogen alpha synuclein antibody (Life Technologies, 32-8100) was used in immunohistochemistry - paraffin section on human samples at 1:200. Acta Neuropathol Commun (2015) ncbi
mouse monoclonal (Syn 211)
  • immunohistochemistry; human; 1:1000; fig 1
In order to study alpha-synuclein overexpression by lack of an additive role of aging in nigrostriatal neurodegeneration, Invitrogen alpha synuclein antibody (Thermo Scientific, MS1572) was used in immunohistochemistry on human samples at 1:1000 (fig 1). Acta Neuropathol Commun (2015) ncbi
mouse monoclonal (Syn 211)
  • immunocytochemistry; human; 1:500; fig 1
  • western blot; human; 1:250; fig 1
In order to study CNS neurons and how alpha-synuclein affects autophagy, vesicle transport, neurite morphology, and axonal degeneration, Invitrogen alpha synuclein antibody (Invitrogen, 328100) was used in immunocytochemistry on human samples at 1:500 (fig 1) and in western blot on human samples at 1:250 (fig 1). Cell Death Dis (2015) ncbi
mouse monoclonal (Syn 211)
  • immunohistochemistry - frozen section; rat; 1:1000
In order to determine if glucose-regulated protein 78 contributes to the development of Parkinson's disease, Invitrogen alpha synuclein antibody (Invitrogen, 32-8100) was used in immunohistochemistry - frozen section on rat samples at 1:1000. Neurobiol Aging (2015) ncbi
domestic rabbit recombinant (14H2L1)
  • western blot; human; 1:1500
In order to examine the impact of nonaggregated alpha-Syn on SNARE-dependent liposome fusion, Invitrogen alpha synuclein antibody (Life Technologies, 701085) was used in western blot on human samples at 1:1500. Biochemistry (2014) ncbi
mouse monoclonal (Syn 211)
  • ELISA; human
In order to investigate the use of surface electromyograph and plasma alpha-synuclein levels as predictors of the freezing of gait seen in patients with Parkinson's disease, Invitrogen alpha synuclein antibody (Invitrogen, AHB0261) was used in ELISA on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (Syn 211)
  • immunohistochemistry - free floating section; rat; 1:1000
In order to study the alpha-synuclein transfers from neurons to oligodendrocytes, Invitrogen alpha synuclein antibody (Invitrogen, syn211) was used in immunohistochemistry - free floating section on rat samples at 1:1000. Glia (2014) ncbi
mouse monoclonal (Syn 211)
  • immunohistochemistry - free floating section; human; 1:2000; fig 2
In order to describe the neurodegeneration and functional deficits resulting from injection of recombinant adeno-associated virus-expressing human wildtype alpha-syn in the rat substantia nigra, Invitrogen alpha synuclein antibody (Invitrogen, AHB0261) was used in immunohistochemistry - free floating section on human samples at 1:2000 (fig 2). PLoS ONE (2013) ncbi
mouse monoclonal (Syn 505)
  • immunohistochemistry; grey mouse lemur; 1:100; fig 2b
In order to assess Microcebusmurinus as a model of age-related synucleinopathy, Invitrogen alpha synuclein antibody (Invitrogen, Syn505) was used in immunohistochemistry on grey mouse lemur samples at 1:100 (fig 2b). Sci Rep (2012) ncbi
mouse monoclonal (Syn 211)
  • immunocytochemistry; human; 1:1000; fig 4
  • western blot; human; 1:2000; fig 4
In order to test if BiP modulates the unfolded protein response, blocks apoptosis, and promotes the survival of nigral dopamine neurons using a rat model of Parkinson disease, Invitrogen alpha synuclein antibody (Invitrogen, 32-8100) was used in immunocytochemistry on human samples at 1:1000 (fig 4) and in western blot on human samples at 1:2000 (fig 4). Mol Ther (2012) ncbi
mouse monoclonal (Syn 211)
  • western blot; human
In order to characterize mice that over express murine alpha-Synuclein, Invitrogen alpha synuclein antibody (Zymed, Syn211) was used in western blot on human samples . PLoS ONE (2011) ncbi
mouse monoclonal (Syn 211)
  • immunohistochemistry - frozen section; rat; 1:1000
In order to compare the aggregation kinetics of unmodified and sumoylated alpha-synuclein, Invitrogen alpha synuclein antibody (Invitrogen, 32-8100) was used in immunohistochemistry - frozen section on rat samples at 1:1000. J Cell Biol (2011) ncbi
mouse monoclonal (Syn 211)
  • western blot; human; 1:1000; fig 6
In order to test if minocycline interacts with reactive oxygen species, Invitrogen alpha synuclein antibody (Zymed, 32-8100) was used in western blot on human samples at 1:1000 (fig 6). J Biol Chem (2011) ncbi
mouse monoclonal (Syn 211)
  • immunocytochemistry; mouse; 1:1000; fig 2
In order to study direct synuclein-induced cell membrane changes, Invitrogen alpha synuclein antibody (NeoMarkers, MS-1572-PIABX) was used in immunocytochemistry on mouse samples at 1:1000 (fig 2). Eur J Neurosci (2010) ncbi
mouse monoclonal (Syn 211)
  • immunohistochemistry - paraffin section; human
In order to study the hypocretin system in patients with Parkinson's disease, Invitrogen alpha synuclein antibody (Zymed, 32-8100) was used in immunohistochemistry - paraffin section on human samples . Brain (2007) ncbi
Santa Cruz Biotechnology
mouse monoclonal (211)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 8a
  • western blot; mouse; 1:5000; fig 8c
Santa Cruz Biotechnology alpha synuclein antibody (Santa Cruz, sc-12767) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 8a) and in western blot on mouse samples at 1:5000 (fig 8c). Diabetologia (2022) ncbi
mouse monoclonal (LB 509)
  • immunohistochemistry - free floating section; human; 1:500; loading ...; fig 3b
  • western blot; human; 1:1000; fig 5d
Santa Cruz Biotechnology alpha synuclein antibody (Santa Cruz, sc-58480) was used in immunohistochemistry - free floating section on human samples at 1:500 (fig 3b) and in western blot on human samples at 1:1000 (fig 5d). Mol Ther Nucleic Acids (2022) ncbi
mouse monoclonal
  • western blot; mouse; loading ...; fig 5a
Santa Cruz Biotechnology alpha synuclein antibody (Santa Cruz, sc-514908) was used in western blot on mouse samples (fig 5a). Adv Sci (Weinh) (2022) ncbi
mouse monoclonal (3H2897)
  • western blot; mouse; 1:500; loading ...; fig 8a
Santa Cruz Biotechnology alpha synuclein antibody (Santa Cruz Biotechnology, sc 69977) was used in western blot on mouse samples at 1:500 (fig 8a). Int J Mol Sci (2020) ncbi
mouse monoclonal (211)
  • immunoprecipitation; mouse; loading ...; fig 8d
  • immunohistochemistry; mouse; 1:50; loading ...; fig 8c
  • western blot; mouse; 1:3000; loading ...; fig 8a
Santa Cruz Biotechnology alpha synuclein antibody (Santa Cruz, sc-12767) was used in immunoprecipitation on mouse samples (fig 8d), in immunohistochemistry on mouse samples at 1:50 (fig 8c) and in western blot on mouse samples at 1:3000 (fig 8a). J Neuroinflammation (2020) ncbi
mouse monoclonal (LB 509)
  • immunohistochemistry; mouse; 1:1000; loading ...; fig 2a
Santa Cruz Biotechnology alpha synuclein antibody (Santa Cruz Biotechnology, sc-58480) was used in immunohistochemistry on mouse samples at 1:1000 (fig 2a). elife (2020) ncbi
mouse monoclonal (3H2897)
  • immunocytochemistry; mouse; loading ...; fig 2f
  • immunohistochemistry; mouse; loading ...; fig 1b
  • western blot; mouse; loading ...; fig 2a
Santa Cruz Biotechnology alpha synuclein antibody (Santa Cruz, sc-69977) was used in immunocytochemistry on mouse samples (fig 2f), in immunohistochemistry on mouse samples (fig 1b) and in western blot on mouse samples (fig 2a). Theranostics (2020) ncbi
mouse monoclonal (211)
  • western blot; human; 1:4000; loading ...; fig 2c
Santa Cruz Biotechnology alpha synuclein antibody (Santa Cruz, sc-12767) was used in western blot on human samples at 1:4000 (fig 2c). Nature (2020) ncbi
mouse monoclonal (3H2897)
  • immunohistochemistry - paraffin section; human; 1:4000; fig 2
Santa Cruz Biotechnology alpha synuclein antibody (Santa Cruz, sc-69977) was used in immunohistochemistry - paraffin section on human samples at 1:4000 (fig 2). Mol Med Rep (2016) ncbi
mouse monoclonal (Syn514)
  • immunohistochemistry - paraffin section; human; 1:500; fig 3
Santa Cruz Biotechnology alpha synuclein antibody (Santa Cruz, sc-32279) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 3). Mol Med Rep (2016) ncbi
mouse monoclonal (3H2897)
  • immunocytochemistry; human; 1:100; fig 1
  • western blot; human; 1:100; fig 2
Santa Cruz Biotechnology alpha synuclein antibody (Santa Cruz, sc-69977) was used in immunocytochemistry on human samples at 1:100 (fig 1) and in western blot on human samples at 1:100 (fig 2). Nature (2016) ncbi
mouse monoclonal (211)
  • western blot; human; 1:1000; fig 3
Santa Cruz Biotechnology alpha synuclein antibody (Santa Cruz, sc-12767) was used in western blot on human samples at 1:1000 (fig 3). PLoS ONE (2015) ncbi
mouse monoclonal (LB 509)
  • immunocytochemistry; human; 1:10,000
In order to investigate how endolysosomal dysfunction causes Parkinson's disease-related neurodegeneration, Santa Cruz Biotechnology alpha synuclein antibody (Santa Cruz Biotechnology, sc-58480) was used in immunocytochemistry on human samples at 1:10,000. J Neurosci (2015) ncbi
mouse monoclonal (211)
  • western blot; human; 1:1000
Santa Cruz Biotechnology alpha synuclein antibody (Santa Cruz, SC-12767) was used in western blot on human samples at 1:1000. J Biol Chem (2015) ncbi
mouse monoclonal (211)
  • immunohistochemistry - frozen section; rat; 1:2000
Santa Cruz Biotechnology alpha synuclein antibody (Santa Cruz, sc-12767) was used in immunohistochemistry - frozen section on rat samples at 1:2000. PLoS ONE (2014) ncbi
mouse monoclonal (LB 509)
  • western blot; human; fig 6
In order to study the existance of alpha- and beta-synuclein predomonantly as oligomers in normal neuronal and non-neuronal cells, Santa Cruz Biotechnology alpha synuclein antibody (Santa Cruz, LB509) was used in western blot on human samples (fig 6). J Biol Chem (2013) ncbi
mouse monoclonal (211)
  • western blot; human; fig 6
In order to study the existance of alpha- and beta-synuclein predomonantly as oligomers in normal neuronal and non-neuronal cells, Santa Cruz Biotechnology alpha synuclein antibody (Santa Cruz, 211) was used in western blot on human samples (fig 6). J Biol Chem (2013) ncbi
BioLegend
mouse monoclonal (P-syn/81A)
  • immunohistochemistry - free floating section; mouse; 1:10,000; loading ...; fig 2a
BioLegend alpha synuclein antibody (BioLegend, 825701) was used in immunohistochemistry - free floating section on mouse samples at 1:10,000 (fig 2a). Acta Neuropathol Commun (2022) ncbi
mouse monoclonal (P-syn/81A)
  • western blot; mouse; 1:2000; loading ...
BioLegend alpha synuclein antibody (Biolegend, 825701) was used in western blot on mouse samples at 1:2000. Redox Biol (2021) ncbi
mouse monoclonal (4B12/Synuclein)
  • immunohistochemistry; human; 1:300; loading ...; fig 1c
  • western blot; human; 1:1000; loading ...; fig 1e
BioLegend alpha synuclein antibody (Biolegend,, 807801) was used in immunohistochemistry on human samples at 1:300 (fig 1c) and in western blot on human samples at 1:1000 (fig 1e). Acta Neuropathol (2021) ncbi
mouse monoclonal (Syn 202)
  • immunohistochemistry; mouse; loading ...; fig 1a
BioLegend alpha synuclein antibody (BioLegend, SYN202) was used in immunohistochemistry on mouse samples (fig 1a). Eneuro (2021) ncbi
mouse monoclonal (P-syn/81A)
  • immunocytochemistry; roundworm ; fig 5j
BioLegend alpha synuclein antibody (Biolegend, 825702) was used in immunocytochemistry on roundworm samples (fig 5j). Adv Sci (Weinh) (2019) ncbi
mouse monoclonal (P-syn/81A)
  • immunohistochemistry - frozen section; mouse; 1:3000; loading ...; fig 2b
BioLegend alpha synuclein antibody (Biolegend, 825702) was used in immunohistochemistry - frozen section on mouse samples at 1:3000 (fig 2b). Int J Mol Sci (2019) ncbi
mouse monoclonal (P-syn/81A)
  • immunohistochemistry - frozen section; mouse; 1:5000; loading ...; fig 1c
BioLegend alpha synuclein antibody (Covance/BioLegend, MMS-5091) was used in immunohistochemistry - frozen section on mouse samples at 1:5000 (fig 1c). Acta Neuropathol (2019) ncbi
mouse monoclonal (P-syn/81A)
  • immunohistochemistry; mouse; 1:10,000; loading ...; fig 2b
BioLegend alpha synuclein antibody (BioLengend, 825701) was used in immunohistochemistry on mouse samples at 1:10,000 (fig 2b). Acta Neuropathol (2019) ncbi
mouse monoclonal (Syn303)
  • western blot; human; fig 1a
BioLegend alpha synuclein antibody (Biolegend, 303) was used in western blot on human samples (fig 1a). Neuron (2018) ncbi
mouse monoclonal (Syn303)
  • western blot; human; 1:1000; loading ...; fig 1e
In order to test if glucocerebrosidase activation reduces alpha-synuclein levels, BioLegend alpha synuclein antibody (BioLegend, syn303) was used in western blot on human samples at 1:1000 (fig 1e). J Neurosci (2016) ncbi
mouse monoclonal (4B12/Synuclein)
  • immunohistochemistry - frozen section; rat; 1:1000; loading ...; fig 1a
  • western blot; rat; 1:1000; loading ...; fig 2c
BioLegend alpha synuclein antibody (Signet, 4B12) was used in immunohistochemistry - frozen section on rat samples at 1:1000 (fig 1a) and in western blot on rat samples at 1:1000 (fig 2c). PLoS ONE (2014) ncbi
Novus Biologicals
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:400; loading ...; fig 6c
Novus Biologicals alpha synuclein antibody (Novus, NBP2-15365) was used in immunohistochemistry on mouse samples at 1:400 (fig 6c). Acta Neuropathol Commun (2020) ncbi
Cell Signaling Technology
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig s4c
  • western blot; human; 1:1000; loading ...; fig s4f
Cell Signaling Technology alpha synuclein antibody (Cell Signaling, 2628S) was used in western blot on mouse samples at 1:1000 (fig s4c) and in western blot on human samples at 1:1000 (fig s4f). Cell Death Dis (2022) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 1e
Cell Signaling Technology alpha synuclein antibody (Cell Signaling Technology, 2642) was used in western blot on human samples at 1:1000 (fig 1e). Acta Neuropathol (2021) ncbi
domestic rabbit monoclonal (D37A6)
  • immunocytochemistry; human; loading ...
Cell Signaling Technology alpha synuclein antibody (Cell Signaling, D37A6) was used in immunocytochemistry on human samples . Acta Neuropathol Commun (2021) ncbi
domestic rabbit monoclonal (D37A6)
  • immunohistochemistry; mouse; 1:1000; loading ...; fig 2a
Cell Signaling Technology alpha synuclein antibody (Cell Signaling Technology, 4179) was used in immunohistochemistry on mouse samples at 1:1000 (fig 2a). elife (2020) ncbi
domestic rabbit monoclonal (D37A6)
  • immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig 4g
  • immunohistochemistry; mouse; 1:100; loading ...; fig 6a
Cell Signaling Technology alpha synuclein antibody (Cell Signaling, 4179S) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 4g) and in immunohistochemistry on mouse samples at 1:100 (fig 6a). Nat Commun (2020) ncbi
domestic rabbit monoclonal (D37A6)
  • immunocytochemistry; mouse; loading ...; fig 2f
  • immunohistochemistry; mouse; loading ...; fig 1b
  • western blot; mouse; loading ...; fig 2a
Cell Signaling Technology alpha synuclein antibody (CST, 4179) was used in immunocytochemistry on mouse samples (fig 2f), in immunohistochemistry on mouse samples (fig 1b) and in western blot on mouse samples (fig 2a). Theranostics (2020) ncbi
mouse monoclonal (Syn204)
  • western blot; mouse; loading ...; fig 1a, 1b
Cell Signaling Technology alpha synuclein antibody (Cell Signaling, 2647) was used in western blot on mouse samples (fig 1a, 1b). Neuropsychiatr Dis Treat (2020) ncbi
domestic rabbit monoclonal (D37A6)
  • immunohistochemistry - frozen section; mouse; 1:500; loading ...
In order to assess the effect of increased Parkin deletion mutagenesis in the absence of mitochondrial quality control, Cell Signaling Technology alpha synuclein antibody (Cell Signaling, 4179) was used in immunohistochemistry - frozen section on mouse samples at 1:500. Neurobiol Dis (2017) ncbi
domestic rabbit monoclonal (D37A6)
  • immunohistochemistry - paraffin section; mouse; 1:250; fig s1
Cell Signaling Technology alpha synuclein antibody (Cell signaling, 4179) was used in immunohistochemistry - paraffin section on mouse samples at 1:250 (fig s1). EMBO J (2016) ncbi
domestic rabbit monoclonal (D37A6)
  • immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig 3c
  • western blot; mouse; 1:1000; loading ...; fig s4b
In order to demonstrate that sustained Lmx1a and Lmx1b expression is needed for the survival of adult midbrain dopaminergic neurons, Cell Signaling Technology alpha synuclein antibody (Cell Signaling Technology, 4179P) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 3c) and in western blot on mouse samples at 1:1000 (fig s4b). Proc Natl Acad Sci U S A (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 1
  • western blot; mouse; fig 3
Cell Signaling Technology alpha synuclein antibody (Cell Signaling, 2642) was used in western blot on human samples (fig 1) and in western blot on mouse samples (fig 3). Mol Neurodegener (2016) ncbi
mouse monoclonal (Syn204)
  • western blot; human; 1:500; loading ...; fig 1a
Cell Signaling Technology alpha synuclein antibody (Cell Signaling Technology, Syn204) was used in western blot on human samples at 1:500 (fig 1a). PLoS ONE (2015) ncbi
domestic rabbit monoclonal (D37A6)
  • immunocytochemistry; mouse; fig 2
In order to study microfluidic-based reconstructed neuronal network and beta-amyloic inducing a dying-back process and remote trans-synaptic alterations, Cell Signaling Technology alpha synuclein antibody (cell signaling, 4179) was used in immunocytochemistry on mouse samples (fig 2). Acta Neuropathol Commun (2014) ncbi
Wako Chemicals USA
monoclonal (pSyn#64)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; fig 5c
Wako Chemicals USA alpha synuclein antibody (Wako, 014-20281) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 5c). Nat Commun (2021) ncbi
monoclonal (pSyn#64)
  • immunohistochemistry; mouse; fig 2
Wako Chemicals USA alpha synuclein antibody (Wako Chemicals, psyn#64) was used in immunohistochemistry on mouse samples (fig 2). Acta Neuropathol Commun (2021) ncbi
monoclonal (pSyn#64)
  • immunohistochemistry - paraffin section; human; 1:1000
In order to suggest that the clinical feature of choreoathetosis in behavioral variant of frontotemporal dementia might be associated with the basophilic inclusion body disease subtype of frontotemporal lobar degeneration, Wako Chemicals USA alpha synuclein antibody (Wako, pSyn#64) was used in immunohistochemistry - paraffin section on human samples at 1:1000. Acta Neuropathol Commun (2016) ncbi
monoclonal (pSyn#64)
  • immunocytochemistry; mouse; 1:800; fig 2
  • immunocytochemistry; human; 1:2000; fig 5
Wako Chemicals USA alpha synuclein antibody (Wako, pSyn#64) was used in immunocytochemistry on mouse samples at 1:800 (fig 2) and in immunocytochemistry on human samples at 1:2000 (fig 5). Acta Neuropathol Commun (2016) ncbi
monoclonal (pSyn#64)
  • immunohistochemistry - paraffin section; human; 1:5000; loading ...; tbl 1
In order to examine eosinophilic neuronal cytoplasmic inclusions, Wako Chemicals USA alpha synuclein antibody (WAKO, pSyn#64) was used in immunohistochemistry - paraffin section on human samples at 1:5000 (tbl 1). Neuropathology (2016) ncbi
monoclonal (pSyn#64)
  • immunohistochemistry - free floating section; mouse
  • immunocytochemistry; human; 1:800
  • western blot; human; 1:5000
Wako Chemicals USA alpha synuclein antibody (Wako, 014-20281) was used in immunohistochemistry - free floating section on mouse samples , in immunocytochemistry on human samples at 1:800 and in western blot on human samples at 1:5000. J Biol Chem (2015) ncbi
monoclonal (pSyn#64)
  • immunohistochemistry - paraffin section; human; 1:10,000
Wako Chemicals USA alpha synuclein antibody (WAKO, 014-20281) was used in immunohistochemistry - paraffin section on human samples at 1:10,000. Acta Neuropathol (2014) ncbi
BD Biosciences
mouse monoclonal (42/?-Synuclein)
  • western blot; mouse; fig 3e
BD Biosciences alpha synuclein antibody (BD, 610786) was used in western blot on mouse samples (fig 3e). Mol Ther Nucleic Acids (2022) ncbi
mouse monoclonal (42/?-Synuclein)
  • immunocytochemistry; human; loading ...; fig 2a
  • immunocytochemistry; rat; fig 2b
BD Biosciences alpha synuclein antibody (BD Biosciences, 610786) was used in immunocytochemistry on human samples (fig 2a) and in immunocytochemistry on rat samples (fig 2b). Mol Brain (2021) ncbi
mouse monoclonal (42/?-Synuclein)
  • western blot; human; loading ...; fig s1h
BD Biosciences alpha synuclein antibody (BD Bioscience, 610786) was used in western blot on human samples (fig s1h). Cell Rep (2021) ncbi
mouse monoclonal (42/?-Synuclein)
  • immunohistochemistry; mouse; 1:5000; loading ...; fig s2a
BD Biosciences alpha synuclein antibody (BD Pharmingen), 610786) was used in immunohistochemistry on mouse samples at 1:5000 (fig s2a). PLoS ONE (2021) ncbi
mouse monoclonal (42/?-Synuclein)
  • western blot; mouse; 1:1000; loading ...; fig 2a
BD Biosciences alpha synuclein antibody (BD Biosciences, 610786) was used in western blot on mouse samples at 1:1000 (fig 2a). J Parkinsons Dis (2021) ncbi
mouse monoclonal (42/?-Synuclein)
  • immunocytochemistry; human; 1:100; loading ...; fig 5a
BD Biosciences alpha synuclein antibody (BD Biosciences, 610786) was used in immunocytochemistry on human samples at 1:100 (fig 5a). Acta Neuropathol (2021) ncbi
mouse monoclonal (42/?-Synuclein)
  • western blot knockout validation; human; 1:1000; loading ...; fig 2a
  • immunohistochemistry - paraffin section; human; 1:500; fig 6a
BD Biosciences alpha synuclein antibody (BD Biosciences, 610786) was used in western blot knockout validation on human samples at 1:1000 (fig 2a) and in immunohistochemistry - paraffin section on human samples at 1:500 (fig 6a). Sci Rep (2021) ncbi
mouse monoclonal (42/?-Synuclein)
  • immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig 1b
BD Biosciences alpha synuclein antibody (BD Bioscience, 610786) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 1b). elife (2020) ncbi
mouse monoclonal (42/?-Synuclein)
  • immunocytochemistry; human; 1:250; loading ...; fig 3f
  • western blot; human; 1:1000; loading ...; fig 1b
BD Biosciences alpha synuclein antibody (BD Biosciences, 610786) was used in immunocytochemistry on human samples at 1:250 (fig 3f) and in western blot on human samples at 1:1000 (fig 1b). Nat Commun (2020) ncbi
mouse monoclonal (42/?-Synuclein)
  • western blot; mouse; 1:1000; loading ...; fig 1
BD Biosciences alpha synuclein antibody (BD Transduction Laboratories, 42) was used in western blot on mouse samples at 1:1000 (fig 1). Neurobiol Aging (2020) ncbi
mouse monoclonal (42/?-Synuclein)
  • immunohistochemistry; human; 1:2000; loading ...; tbl 1
BD Biosciences alpha synuclein antibody (BD Biosciences, 42) was used in immunohistochemistry on human samples at 1:2000 (tbl 1). Acta Neuropathol Commun (2020) ncbi
mouse monoclonal (42/?-Synuclein)
  • immunocytochemistry knockout validation; human; 1:500; loading ...; fig 2a
  • western blot knockout validation; human; loading ...; fig 2b1
BD Biosciences alpha synuclein antibody (BD Biosciences, 610786) was used in immunocytochemistry knockout validation on human samples at 1:500 (fig 2a) and in western blot knockout validation on human samples (fig 2b1). Sci Rep (2019) ncbi
mouse monoclonal (42/?-Synuclein)
  • immunohistochemistry - paraffin section; rat; 1:1000; loading ...; fig 7c
BD Biosciences alpha synuclein antibody (BD Biosciences, 610786) was used in immunohistochemistry - paraffin section on rat samples at 1:1000 (fig 7c). Nat Commun (2019) ncbi
mouse monoclonal (42/?-Synuclein)
  • western blot; human; loading ...; fig 5e
BD Biosciences alpha synuclein antibody (BD, 610786) was used in western blot on human samples (fig 5e). Mol Cell (2019) ncbi
mouse monoclonal (42/?-Synuclein)
  • immunoprecipitation; mouse; loading ...; fig 3d
  • western blot; mouse; loading ...; fig 3d
BD Biosciences alpha synuclein antibody (BD Transduction Laboratories, 610786) was used in immunoprecipitation on mouse samples (fig 3d) and in western blot on mouse samples (fig 3d). Free Radic Biol Med (2018) ncbi
mouse monoclonal (42/?-Synuclein)
  • western blot knockout validation; mouse; loading ...; fig 7
BD Biosciences alpha synuclein antibody (BD Biosciences, 610786) was used in western blot knockout validation on mouse samples (fig 7). J Comp Neurol (2018) ncbi
mouse monoclonal (42/?-Synuclein)
  • other; human; loading ...; fig 1a, 1b
  • western blot; human; loading ...; fig s2, s4, s5
BD Biosciences alpha synuclein antibody (BD, 610786) was used in other on human samples (fig 1a, 1b) and in western blot on human samples (fig s2, s4, s5). Anal Chem (2017) ncbi
mouse monoclonal (42/?-Synuclein)
  • western blot; human; loading ...; fig 3e
BD Biosciences alpha synuclein antibody (BD Biosciences, 610786) was used in western blot on human samples (fig 3e). Science (2017) ncbi
mouse monoclonal (42/?-Synuclein)
  • western blot; mouse; loading ...; tbl 1
In order to elucidate the contribution of the Sac phosphatase domain of Synaptojanin 1 to neurological symptoms, BD Biosciences alpha synuclein antibody (BD biosciences, 610786) was used in western blot on mouse samples (tbl 1). Neuron (2017) ncbi
mouse monoclonal (42/?-Synuclein)
  • immunocytochemistry; rat; 1:500; loading ...; fig 5c
  • western blot; rat; 1:500; loading ...; fig 5e
In order to analyze the impact of alpha-synuclein on mitochondrial responses to oxidative stress in neural cells, BD Biosciences alpha synuclein antibody (BD Biosciences GmbH, 610786) was used in immunocytochemistry on rat samples at 1:500 (fig 5c) and in western blot on rat samples at 1:500 (fig 5e). Sci Rep (2017) ncbi
mouse monoclonal (42/?-Synuclein)
  • western blot knockout validation; mouse; 1:300; fig 2c
BD Biosciences alpha synuclein antibody (BD, 610786) was used in western blot knockout validation on mouse samples at 1:300 (fig 2c). J Neuroinflammation (2016) ncbi
mouse monoclonal (42/?-Synuclein)
  • western blot; human; 1:2000; fig 5
  • immunohistochemistry knockout validation; mouse; fig 1
  • western blot knockout validation; mouse; 1:2000; fig 2
In order to characterize modulation of retinal iron homeostasis by facilitating the update of transferrin-bound iron by alpha-synuclein which may be a visual manifestation of Parkinson's disease, BD Biosciences alpha synuclein antibody (BD transduction, 610786) was used in western blot on human samples at 1:2000 (fig 5), in immunohistochemistry knockout validation on mouse samples (fig 1) and in western blot knockout validation on mouse samples at 1:2000 (fig 2). Free Radic Biol Med (2016) ncbi
mouse monoclonal (42/?-Synuclein)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 4a
In order to examine coenzyme Q10 levels in patients with multiple system atrophy, BD Biosciences alpha synuclein antibody (BD Bioscience, 610786) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 4a). J Neuropathol Exp Neurol (2016) ncbi
mouse monoclonal (42/?-Synuclein)
  • immunocytochemistry; mouse; fig 2
In order to assess reduction of pyramidal cell excitability due to intracellular solube alpha-synuclein oligomers, BD Biosciences alpha synuclein antibody (BD Biosciences, 610786) was used in immunocytochemistry on mouse samples (fig 2). J Physiol (2016) ncbi
mouse monoclonal (42/?-Synuclein)
  • western blot knockout validation; mouse; 1:1000; fig 3
BD Biosciences alpha synuclein antibody (BD Biosciences, 610786) was used in western blot knockout validation on mouse samples at 1:1000 (fig 3). Sci Rep (2015) ncbi
mouse monoclonal (42/?-Synuclein)
  • immunocytochemistry; human; fig 7
  • western blot; human; fig 4
BD Biosciences alpha synuclein antibody (BD Biosciences, 610786) was used in immunocytochemistry on human samples (fig 7) and in western blot on human samples (fig 4). Mol Pharmacol (2015) ncbi
mouse monoclonal (42/?-Synuclein)
  • immunocytochemistry; mouse; 1:500
In order to investigate how endolysosomal dysfunction causes Parkinson's disease-related neurodegeneration, BD Biosciences alpha synuclein antibody (BD Biosciences, 610786) was used in immunocytochemistry on mouse samples at 1:500. J Neurosci (2015) ncbi
mouse monoclonal (42/?-Synuclein)
  • western blot; mouse; 1:1000; loading ...
BD Biosciences alpha synuclein antibody (BD Biosciences, 610786) was used in western blot on mouse samples at 1:1000. Mol Neurobiol (2015) ncbi
mouse monoclonal (42/?-Synuclein)
  • immunohistochemistry - frozen section; rat; 1:1000
  • western blot; rat; 1:1000
BD Biosciences alpha synuclein antibody (BD Biosciences, 610786) was used in immunohistochemistry - frozen section on rat samples at 1:1000 and in western blot on rat samples at 1:1000. PLoS ONE (2014) ncbi
mouse monoclonal (42/?-Synuclein)
  • western blot; mouse
In order to study the induction of dopaminergic neurodegeneration by VPS35 mutations associated with Parkinson's disease, BD Biosciences alpha synuclein antibody (BD Biosciences, 42) was used in western blot on mouse samples . Hum Mol Genet (2014) ncbi
mouse monoclonal (42/?-Synuclein)
  • western blot; rat; loading ...; fig 4a
BD Biosciences alpha synuclein antibody (BD Transduction, 610786) was used in western blot on rat samples (fig 4a). Nat Neurosci (2014) ncbi
mouse monoclonal (42/?-Synuclein)
  • western blot; human; 1:1000; fig 5
In order to study cellular inclusions in the Krabbe brain, BD Biosciences alpha synuclein antibody (BD Biosciences, 610786) was used in western blot on human samples at 1:1000 (fig 5). J Pathol (2014) ncbi
mouse monoclonal (42/?-Synuclein)
  • western blot; rat; 1:2000
BD Biosciences alpha synuclein antibody (BD Biosciences, 610786) was used in western blot on rat samples at 1:2000. Clin Psychopharmacol Neurosci (2012) ncbi
mouse monoclonal (42/?-Synuclein)
  • immunohistochemistry; mouse
  • western blot; mouse
In order to examine the neuronal cell death in the spinal cords of mSOD1 and wtSOD1 mice, BD Biosciences alpha synuclein antibody (BD Transduction Lab, 610786) was used in immunohistochemistry on mouse samples and in western blot on mouse samples . J Comp Neurol (2007) ncbi
Leica Biosystems
mouse monoclonal (KM51)
  • immunohistochemistry - frozen section; human; 1:20; loading ...; fig 3a
Leica Biosystems alpha synuclein antibody (Novocastra, NCL-L-ASYN) was used in immunohistochemistry - frozen section on human samples at 1:20 (fig 3a). J Parkinsons Dis (2021) ncbi
mouse monoclonal (KM51)
  • immunohistochemistry; human; 1:50; fig 1
Leica Biosystems alpha synuclein antibody (Novocastra, KN51) was used in immunohistochemistry on human samples at 1:50 (fig 1). Acta Neuropathol Commun (2021) ncbi
mouse monoclonal (KM51)
  • immunohistochemistry - paraffin section; human; 1:500; loading ...
In order to examine the mutation spectrum of the TANK-Binding Kinase 1 gene and its associated phenotypic spectrum in patients with FTD, ALS or FTD plus ALS, Leica Biosystems alpha synuclein antibody (Novocastra, KM51) was used in immunohistochemistry - paraffin section on human samples at 1:500. Hum Mutat (2017) ncbi
mouse monoclonal (KM51)
  • immunohistochemistry - paraffin section; human; 1:500; loading ...
In order to detail the neuropathological features of the anti-IgLON5 syndrome in order to diagnose patients, Leica Biosystems alpha synuclein antibody (Novocastra, KM51) was used in immunohistochemistry - paraffin section on human samples at 1:500. Acta Neuropathol (2016) ncbi
mouse monoclonal (KM51)
  • immunohistochemistry - paraffin section; human; 1:200
In order to investigate the relationship between ZnT3 and PSD95, cognition and pathology, Leica Biosystems alpha synuclein antibody (Leica Biosystems, KM51) was used in immunohistochemistry - paraffin section on human samples at 1:200. Neurobiol Aging (2014) ncbi
mouse monoclonal (KM51)
  • immunohistochemistry - paraffin section; human; 1:400
Leica Biosystems alpha synuclein antibody (Leica Biosystems, NCL-L-ASYN) was used in immunohistochemistry - paraffin section on human samples at 1:400. Acta Neuropathol (2014) ncbi
MilliporeSigma
mouse monoclonal (syn211)
  • western blot; mouse; loading ...; fig 3
MilliporeSigma alpha synuclein antibody (Sigma-Aldrich, Syn211) was used in western blot on mouse samples (fig 3). Int J Mol Sci (2021) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; 1:1000; loading ...; fig 1c
  • western blot; human; 1:1000; loading ...; fig 2
  • immunohistochemistry - paraffin section; mouse; 1:1000; loading ...; fig 4a
  • western blot; mouse; 1:1000; loading ...; fig 6a
In order to test if arsenic promotes the accumulation of toxic synuclein aggregates and stimulates autophagy, MilliporeSigma alpha synuclein antibody (Sigma, S-3062) was used in immunocytochemistry on human samples at 1:1000 (fig 1c), in western blot on human samples at 1:1000 (fig 2), in immunohistochemistry - paraffin section on mouse samples at 1:1000 (fig 4a) and in western blot on mouse samples at 1:1000 (fig 6a). Toxicol Sci (2016) ncbi
mouse monoclonal (syn211)
  • immunocytochemistry; mouse; 1:1000; fig 2
In order to study direct synuclein-induced cell membrane changes, MilliporeSigma alpha synuclein antibody (NeoMarkers, MS-1572-PIABX) was used in immunocytochemistry on mouse samples at 1:1000 (fig 2). Eur J Neurosci (2010) ncbi
Articles Reviewed
  1. Ho P, Chang E, Leung C, Liu H, Malki Y, Pang S, et al. Long-term inhibition of mutant LRRK2 hyper-kinase activity reduced mouse brain α-synuclein oligomers without adverse effects. NPJ Parkinsons Dis. 2022;8:115 pubmed publisher
  2. Pieger K, Schmitt V, Gauer C, Gie xdf l N, Prots I, Winner B, et al. Translocation of Distinct Alpha Synuclein Species from the Nucleus to Neuronal Processes during Neuronal Differentiation. Biomolecules. 2022;12: pubmed publisher
  3. Duperrier S, Bortolozzi A, Sgambato V. Increased Expression of Alpha-, Beta-, and Gamma-Synucleins in Brainstem Regions of a Non-Human Primate Model of Parkinson's Disease. Int J Mol Sci. 2022;23: pubmed publisher
  4. Gao H, Sun H, Yan N, Zhao P, Xu H, Zheng W, et al. ATP13A2 Declines Zinc-Induced Accumulation of α-Synuclein in a Parkinson's Disease Model. Int J Mol Sci. 2022;23: pubmed publisher
  5. Merino B, Casanueva xc1 lvarez E, Quesada I, Gonz xe1 lez Casimiro C, Fern xe1 ndez D xed az C, Postigo Casado T, et al. Insulin-degrading enzyme ablation in mouse pancreatic alpha cells triggers cell proliferation, hyperplasia and glucagon secretion dysregulation. Diabetologia. 2022;65:1375-1389 pubmed publisher
  6. Piccardo P, Cervenak J, Goldmann W, Stewart P, Pomeroy K, Gregori L, et al. Experimental Bovine Spongiform Encephalopathy in Squirrel Monkeys: The Same Complex Proteinopathy Appearing after Very Different Incubation Times. Pathogens. 2022;11: pubmed publisher
  7. Creed R, Memon A, Komaragiri S, Barodia S, Goldberg M. Analysis of hemisphere-dependent effects of unilateral intrastriatal injection of α-synuclein pre-formed fibrils on mitochondrial protein levels, dynamics, and function. Acta Neuropathol Commun. 2022;10:78 pubmed publisher
  8. Jia F, Li H, Jiao Q, Li C, Fu L, Cui C, et al. Deubiquitylase OTUD3 prevents Parkinson's disease through stabilizing iron regulatory protein 2. Cell Death Dis. 2022;13:418 pubmed publisher
  9. Nuber S, Chung C, Tardiff D, Bechade P, McCaffery T, Shimanaka K, et al. A Brain-Penetrant Stearoyl-CoA Desaturase Inhibitor Reverses α-Synuclein Toxicity. Neurotherapeutics. 2022;19:1018-1036 pubmed publisher
  10. Permanne B, Sand A, Ousson S, N xe9 ny M, Hantson J, Schubert R, et al. O-GlcNAcase Inhibitor ASN90 is a Multimodal Drug Candidate for Tau and α-Synuclein Proteinopathies. ACS Chem Neurosci. 2022;13:1296-1314 pubmed publisher
  11. Ghanem S, Majbour N, Vaikath N, Ardah M, Erskine D, Jensen N, et al. α-Synuclein phosphorylation at serine 129 occurs after initial protein deposition and inhibits seeded fibril formation and toxicity. Proc Natl Acad Sci U S A. 2022;119:e2109617119 pubmed publisher
  12. Stein C, McLendon J, Witmer N, Boudreau R. Modulation of miR-181 influences dopaminergic neuronal degeneration in a mouse model of Parkinson's disease. Mol Ther Nucleic Acids. 2022;28:1-15 pubmed publisher
  13. Javanshiri K, Drakenberg T, Haglund M, Englund E. Cardiac Alpha-Synuclein Is Present in Alpha-Synucleinopathies. J Parkinsons Dis. 2022;12:1125-1131 pubmed publisher
  14. Chen G, Ahn E, Kang S, Xia Y, Liu X, Zhang Z, et al. UNC5C Receptor Proteolytic Cleavage by Active AEP Promotes Dopaminergic Neuronal Degeneration in Parkinson's Disease. Adv Sci (Weinh). 2022;9:e2103396 pubmed publisher
  15. Zhang C, Zhao M, Wang B, Su Z, Guo B, Qin L, et al. The Nrf2-NLRP3-caspase-1 axis mediates the neuroprotective effects of Celastrol in Parkinson's disease. Redox Biol. 2021;47:102134 pubmed publisher
  16. Mroczek K, Fernando S, Fisher P, Annesley S. Interactions and Cytotoxicity of Human Neurodegeneration- Associated Proteins Tau and α-Synuclein in the Simple Model Dictyostelium discoideum. Front Cell Dev Biol. 2021;9:741662 pubmed publisher
  17. Cai M, Chai S, Xiong T, Wei J, Mao W, Zhu Y, et al. Aberrant Expression of Circulating MicroRNA Leads to the Dysregulation of Alpha-Synuclein and Other Pathogenic Genes in Parkinson's Disease. Front Cell Dev Biol. 2021;9:695007 pubmed publisher
  18. Villanueva E, Tresse E, Liu Y, Duarte J, Jimenez Duran G, Ejlerskov P, et al. Neuronal TNFα, Not α-Syn, Underlies PDD-Like Disease Progression in IFNβ-KO Mice. Ann Neurol. 2021;90:789-807 pubmed publisher
  19. Zhao J, Lu W, Ren Y, Fu Y, Martens Y, Shue F, et al. Apolipoprotein E regulates lipid metabolism and α-synuclein pathology in human iPSC-derived cerebral organoids. Acta Neuropathol. 2021;142:807-825 pubmed publisher
  20. Umeda T, Hatanaka Y, Sakai A, Tomiyama T. Nasal Rifampicin Improves Cognition in a Mouse Model of Dementia with Lewy Bodies by Reducing α-Synuclein Oligomers. Int J Mol Sci. 2021;22: pubmed publisher
  21. Albanese F, Mercatelli D, Finetti L, Lamonaca G, Pizzi S, Shimshek D, et al. Constitutive silencing of LRRK2 kinase activity leads to early glucocerebrosidase deregulation and late impairment of autophagy in vivo. Neurobiol Dis. 2021;159:105487 pubmed publisher
  22. Dagra A, Miller D, Lin M, Gopinath A, Shaerzadeh F, Harris S, et al. α-Synuclein-induced dysregulation of neuronal activity contributes to murine dopamine neuron vulnerability. NPJ Parkinsons Dis. 2021;7:76 pubmed publisher
  23. Yuste Checa P, Trinkaus V, Riera Tur I, Imamoglu R, Schaller T, Wang H, et al. The extracellular chaperone Clusterin enhances Tau aggregate seeding in a cellular model. Nat Commun. 2021;12:4863 pubmed publisher
  24. Zhu G, Wang W, Chen C, Tang L, Liang Y, Zhang Z, et al. UHPLC-MS-based metabolomics and chemoinformatics study reveals the neuroprotective effect and chemical characteristic in Parkinson's disease mice after oral administration of Wen-Shen-Yang-Gan decoction. Aging (Albany NY). 2021;13:19510-19528 pubmed publisher
  25. Ha T, Choi Y, Noh H, Cha S, Kim J, Park S. Age-related increase in caveolin-1 expression facilitates cell-to-cell transmission of α-synuclein in neurons. Mol Brain. 2021;14:122 pubmed publisher
  26. Emmenegger M, De Cecco E, Hruska Plochan M, Eninger T, Schneider M, Barth M, et al. LAG3 is not expressed in human and murine neurons and does not modulate α-synucleinopathies. EMBO Mol Med. 2021;13:e14745 pubmed publisher
  27. Anandhan A, Nguyen N, Syal A, Dreher L, Dodson M, Zhang D, et al. NRF2 Loss Accentuates Parkinsonian Pathology and Behavioral Dysfunction in Human α-Synuclein Overexpressing Mice. Aging Dis. 2021;12:964-982 pubmed publisher
  28. Liu D, Guo J, Su J, Svanbergsson A, Yuan L, Haikal C, et al. Differential seeding and propagating efficiency of α-synuclein strains generated in different conditions. Transl Neurodegener. 2021;10:20 pubmed publisher
  29. Kara E, Crimi A, Wiedmer A, Emmenegger M, Manzoni C, Bandrés Ciga S, et al. An integrated genomic approach to dissect the genetic landscape regulating the cell-to-cell transfer of α-synuclein. Cell Rep. 2021;35:109189 pubmed publisher
  30. Polinski N, Martinez T, Gorodinsky A, Gareus R, Sasner M, Herberth M, et al. Decreased glucocerebrosidase activity and substrate accumulation of glycosphingolipids in a novel GBA1 D409V knock-in mouse model. PLoS ONE. 2021;16:e0252325 pubmed publisher
  31. Villar Conde S, Astillero López V, Gonzalez Rodriguez M, Villanueva Anguita P, Saiz Sanchez D, Martinez Marcos A, et al. The Human Hippocampus in Parkinson's Disease: An Integrative Stereological and Proteomic Study. J Parkinsons Dis. 2021;11:1345-1365 pubmed publisher
  32. Boutros S, Raber J, Unni V. Effects of Alpha-Synuclein Targeted Antisense Oligonucleotides on Lewy Body-Like Pathology and Behavioral Disturbances Induced by Injections of Pre-Formed Fibrils in the Mouse Motor Cortex. J Parkinsons Dis. 2021;11:1091-1115 pubmed publisher
  33. Matsui H, Ito J, Matsui N, Uechi T, Onodera O, Kakita A. Cytosolic dsDNA of mitochondrial origin induces cytotoxicity and neurodegeneration in cellular and zebrafish models of Parkinson's disease. Nat Commun. 2021;12:3101 pubmed publisher
  34. Stoyka L, Mahoney C, Thrasher D, Russell D, Cook A, Harris A, et al. Templated α-Synuclein Inclusion Formation Is Independent of Endogenous Tau. Eneuro. 2021;8: pubmed publisher
  35. Grochowska M, Carreras Mascaro A, Boumeester V, Natale D, Breedveld G, Geut H, et al. LRP10 interacts with SORL1 in the intracellular vesicle trafficking pathway in non-neuronal brain cells and localises to Lewy bodies in Parkinson's disease and dementia with Lewy bodies. Acta Neuropathol. 2021;142:117-137 pubmed publisher
  36. Trinkaus V, Riera Tur I, Martinez Sanchez A, Bäuerlein F, Guo Q, Arzberger T, et al. In situ architecture of neuronal α-Synuclein inclusions. Nat Commun. 2021;12:2110 pubmed publisher
  37. Donadio V, Wang Z, Incensi A, Rizzo G, Fileccia E, Vacchiano V, et al. In Vivo Diagnosis of Synucleinopathies: A Comparative Study of Skin Biopsy and RT-QuIC. Neurology. 2021;96:e2513-e2524 pubmed publisher
  38. Martinez Valbuena I, Valenti Azcarate R, Amat Villegas I, Marcilla I, Martí Andrés G, Caballero M, et al. Mixed pathologies in pancreatic β cells from subjects with neurodegenerative diseases and their interaction with prion protein. Acta Neuropathol Commun. 2021;9:64 pubmed publisher
  39. Niu M, Zhao F, Bondelid K, Siedlak S, Torres S, Fujioka H, et al. VPS35 D620N knockin mice recapitulate cardinal features of Parkinson's disease. Aging Cell. 2021;20:e13347 pubmed publisher
  40. Reyes J, Ekmark Lewén S, Perdiki M, Klingstedt T, Hoffmann A, Wiechec E, et al. Accumulation of alpha-synuclein within the liver, potential role in the clearance of brain pathology associated with Parkinson's disease. Acta Neuropathol Commun. 2021;9:46 pubmed publisher
  41. Liu X, Wang Q, Yang Y, Stewart T, Shi M, Soltys D, et al. Reduced erythrocytic CHCHD2 mRNA is associated with brain pathology of Parkinson's disease. Acta Neuropathol Commun. 2021;9:37 pubmed publisher
  42. Shekoohi S, Rajasekaran S, Patel D, Yang S, Liu W, Huang S, et al. Knocking out alpha-synuclein in melanoma cells dysregulates cellular iron metabolism and suppresses tumor growth. Sci Rep. 2021;11:5267 pubmed publisher
  43. Sokratian A, Ziaee J, Kelly K, Chang A, Bryant N, Wang S, et al. Heterogeneity in α-synuclein fibril activity correlates to disease phenotypes in Lewy body dementia. Acta Neuropathol. 2021;141:547-564 pubmed publisher
  44. Baxter P, Márkus N, Dando O, He X, Al Mubarak B, Qiu J, et al. Targeted de-repression of neuronal Nrf2 inhibits α-synuclein accumulation. Cell Death Dis. 2021;12:218 pubmed publisher
  45. De Miranda B, Castro S, Rocha E, Bodle C, Johnson K, Greenamyre J. The industrial solvent trichloroethylene induces LRRK2 kinase activity and dopaminergic neurodegeneration in a rat model of Parkinson's disease. Neurobiol Dis. 2021;153:105312 pubmed publisher
  46. Ryan B, Bengoa Vergniory N, Williamson M, Kirkiz E, Roberts R, Corda G, et al. REST protects dopaminergic neurons from mitochondrial and α-synuclein oligomer pathology in an alpha synuclein overexpressing BAC-transgenic mouse model. J Neurosci. 2021;: pubmed publisher
  47. Campolo M, Filippone A, Biondo C, Mancuso G, Casili G, Lanza M, et al. TLR7/8 in the Pathogenesis of Parkinson's Disease. Int J Mol Sci. 2020;21: pubmed publisher
  48. Chiu C, Weng Y, Huang Y, Chen R, Liu Y, Yeh T, et al. (D620N) VPS35 causes the impairment of Wnt/β-catenin signaling cascade and mitochondrial dysfunction in a PARK17 knockin mouse model. Cell Death Dis. 2020;11:1018 pubmed publisher
  49. Lin L, Petralia R, Lake R, Wang Y, Hoffman D. A novel structure associated with aging is augmented in the DPP6-KO mouse brain. Acta Neuropathol Commun. 2020;8:197 pubmed publisher
  50. Zahedi K, Brooks M, Barone S, Rahmati N, Murray Stewart T, Dunworth M, et al. Ablation of polyamine catabolic enzymes provokes Purkinje cell damage, neuroinflammation, and severe ataxia. J Neuroinflammation. 2020;17:301 pubmed publisher
  51. Bengoa Vergniory N, Faggiani E, Ramos Gonzalez P, Kirkiz E, Connor Robson N, Brown L, et al. CLR01 protects dopaminergic neurons in vitro and in mouse models of Parkinson's disease. Nat Commun. 2020;11:4885 pubmed publisher
  52. Suzuki G, Imura S, Hosokawa M, Katsumata R, Nonaka T, Hisanaga S, et al. α-synuclein strains that cause distinct pathologies differentially inhibit proteasome. elife. 2020;9: pubmed publisher
  53. Niu H, Wang Q, Zhao W, Liu J, Wang D, Muhammad B, et al. IL-1β/IL-1R1 signaling induced by intranasal lipopolysaccharide infusion regulates alpha-Synuclein pathology in the olfactory bulb, substantia nigra and striatum. Brain Pathol. 2020;30:1102-1118 pubmed publisher
  54. Fujita H, Kodama T, du Lac S. Modular output circuits of the fastigial nucleus for diverse motor and nonmotor functions of the cerebellar vermis. elife. 2020;9: pubmed publisher
  55. Cupo R, Shorter J. Skd3 (human ClpB) is a potent mitochondrial protein disaggregase that is inactivated by 3-methylglutaconic aciduria-linked mutations. elife. 2020;9: pubmed publisher
  56. Bozic M, Caus M, Rodrigues Díez R, Pedraza N, Ruiz Ortega M, Garí E, et al. Protective role of renal proximal tubular alpha-synuclein in the pathogenesis of kidney fibrosis. Nat Commun. 2020;11:1943 pubmed publisher
  57. Ninkina N, Tarasova T, Chaprov K, Roman A, Kukharsky M, Kolik L, et al. Alterations in the nigrostriatal system following conditional inactivation of α-synuclein in neurons of adult and aging mice. Neurobiol Aging. 2020;91:76-87 pubmed publisher
  58. Zhang W, Zhou M, Lu W, Gong J, Gao F, Li Y, et al. CNTNAP4 deficiency in dopaminergic neurons initiates parkinsonian phenotypes. Theranostics. 2020;10:3000-3021 pubmed publisher
  59. Hu S, Hu M, Liu J, Zhang B, Zhang Z, Zhou F, et al. Phosphorylation of Tau and α-Synuclein Induced Neurodegeneration in MPTP Mouse Model of Parkinson's Disease. Neuropsychiatr Dis Treat. 2020;16:651-663 pubmed publisher
  60. Yilmazer Hanke D, Mayer T, Müller H, Neugebauer H, Abaei A, Scheuerle A, et al. Histological correlates of postmortem ultra-high-resolution single-section MRI in cortical cerebral microinfarcts. Acta Neuropathol Commun. 2020;8:33 pubmed publisher
  61. Liao X, Cai F, Sun Z, Zhang Y, Wang J, Jiao B, et al. Identification of Alzheimer's disease-associated rare coding variants in the ECE2 gene. JCI Insight. 2020;5: pubmed publisher
  62. Wang X, Ma M, Zhou L, Jiang X, Hao M, Teng R, et al. Autonomic ganglionic injection of α-synuclein fibrils as a model of pure autonomic failure α-synucleinopathy. Nat Commun. 2020;11:934 pubmed publisher
  63. Sampson T, Challis C, Jain N, Moiseyenko A, Ladinsky M, Shastri G, et al. A gut bacterial amyloid promotes α-synuclein aggregation and motor impairment in mice. elife. 2020;9: pubmed publisher
  64. Shahnawaz M, Mukherjee A, Pritzkow S, Méndez N, Rabadia P, Liu X, et al. Discriminating α-synuclein strains in Parkinson's disease and multiple system atrophy. Nature. 2020;578:273-277 pubmed publisher
  65. Köppen J, Schulze A, Machner L, Wermann M, Eichentopf R, Guthardt M, et al. Amyloid-Beta Peptides Trigger Aggregation of Alpha-Synuclein In Vitro. Molecules. 2020;25: pubmed publisher
  66. Williams G, Marmion D, Schonhoff A, Jurkuvenaite A, Won W, Standaert D, et al. T cell infiltration in both human multiple system atrophy and a novel mouse model of the disease. Acta Neuropathol. 2020;139:855-874 pubmed publisher
  67. Metzger J, Matsoff H, Zinnen A, Fleddermann R, Bondarenko V, Simmons H, et al. Post mortem evaluation of inflammation, oxidative stress, and PPARγ activation in a nonhuman primate model of cardiac sympathetic neurodegeneration. PLoS ONE. 2020;15:e0226999 pubmed publisher
  68. Elfarrash S, Jensen N, Ferreira N, Betzer C, Thevathasan J, Diekmann R, et al. Organotypic slice culture model demonstrates inter-neuronal spreading of alpha-synuclein aggregates. Acta Neuropathol Commun. 2019;7:213 pubmed publisher
  69. Burmann B, Gerez J, Matečko Burmann I, Campioni S, Kumari P, Ghosh D, et al. Regulation of α-synuclein by chaperones in mammalian cells. Nature. 2020;577:127-132 pubmed publisher
  70. Park H, Choi D, Park J, Sim C, Park S, Kang S, et al. Scalable and Isotropic Expansion of Tissues with Simply Tunable Expansion Ratio. Adv Sci (Weinh). 2019;6:1901673 pubmed publisher
  71. Ham S, Kim H, Yoon J, Kim H, Song B, Choi J, et al. Therapeutic Evaluation of Synthetic Peucedanocoumarin III in an Animal Model of Parkinson's Disease. Int J Mol Sci. 2019;20: pubmed publisher
  72. Schaser A, Osterberg V, Dent S, Stackhouse T, Wakeham C, Boutros S, et al. Alpha-synuclein is a DNA binding protein that modulates DNA repair with implications for Lewy body disorders. Sci Rep. 2019;9:10919 pubmed publisher
  73. Bieri G, Brahic M, Bousset L, Couthouis J, Kramer N, Ma R, et al. LRRK2 modifies α-syn pathology and spread in mouse models and human neurons. Acta Neuropathol. 2019;137:961-980 pubmed publisher
  74. Hu D, Sun X, Liao X, Zhang X, Zarabi S, Schimmer A, et al. Alpha-synuclein suppresses mitochondrial protease ClpP to trigger mitochondrial oxidative damage and neurotoxicity. Acta Neuropathol. 2019;137:939-960 pubmed publisher
  75. Carballo Carbajal I, Laguna A, Romero Gimenez J, Cuadros T, Bove J, Martinez Vicente M, et al. Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinson's disease pathogenesis. Nat Commun. 2019;10:973 pubmed publisher
  76. Willard A, Isett B, Whalen T, Mastro K, Ki C, Mao X, et al. State transitions in the substantia nigra reticulata predict the onset of motor deficits in models of progressive dopamine depletion in mice. elife. 2019;8: pubmed publisher
  77. Song C, Zhang J, Qi S, Liu Z, Zhang X, Zheng Y, et al. Cardiolipin remodeling by ALCAT1 links mitochondrial dysfunction to Parkinson's diseases. Aging Cell. 2019;18:e12941 pubmed publisher
  78. Adams J, Feuerborn M, Molina J, Wilden A, Adhikari B, Budden T, et al. Autophagy-lysosome pathway alterations and alpha-synuclein up-regulation in the subtype of neuronal ceroid lipofuscinosis, CLN5 disease. Sci Rep. 2019;9:151 pubmed publisher
  79. Fanning S, Haque A, Imberdis T, Baru V, Barrasa M, Nuber S, et al. Lipidomic Analysis of α-Synuclein Neurotoxicity Identifies Stearoyl CoA Desaturase as a Target for Parkinson Treatment. Mol Cell. 2019;73:1001-1014.e8 pubmed publisher
  80. Deng Y, Jiang B, Rankin C, Toyo oka K, Richter M, Maupin Furlow J, et al. Methionine sulfoxide reductase A (MsrA) mediates the ubiquitination of 14-3-3 protein isotypes in brain. Free Radic Biol Med. 2018;129:600-607 pubmed publisher
  81. Angelova D, Brown D. Model Senescent Microglia Induce Disease Related Changes in α-Synuclein Expression and Activity. Biomolecules. 2018;8: pubmed publisher
  82. Ludtmann M, Angelova P, Horrocks M, Choi M, Rodrigues M, Baev A, et al. α-synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson's disease. Nat Commun. 2018;9:2293 pubmed publisher
  83. Delic V, Chandra S, Abdelmotilib H, Maltbie T, Wang S, Kem D, et al. Sensitivity and specificity of phospho-Ser129 ?-synuclein monoclonal antibodies. J Comp Neurol. 2018;526:1978-1990 pubmed publisher
  84. Zunke F, Moise A, Belur N, Gelyana E, Stojkovska I, Dzaferbegovic H, et al. Reversible Conformational Conversion of α-Synuclein into Toxic Assemblies by Glucosylceramide. Neuron. 2018;97:92-107.e10 pubmed publisher
  85. Je G, Croop B, Basu S, Tang J, Han K, Kim Y. Endogenous Alpha-Synuclein Protein Analysis from Human Brain Tissues Using Single-Molecule Pull-Down Assay. Anal Chem. 2017;89:13044-13048 pubmed publisher
  86. Zhang S, Eitan E, Wu T, Mattson M. Intercellular transfer of pathogenic α-synuclein by extracellular vesicles is induced by the lipid peroxidation product 4-hydroxynonenal. Neurobiol Aging. 2018;61:52-65 pubmed publisher
  87. Wang J, Han X, Leu N, Sterling S, Kurosaka S, Fina M, et al. Protein arginylation targets alpha synuclein, facilitates normal brain health, and prevents neurodegeneration. Sci Rep. 2017;7:11323 pubmed publisher
  88. Takahashi Y, Wu J, Suzuki K, Martínez Redondo P, Li M, Liao H, et al. Integration of CpG-free DNA induces de novo methylation of CpG islands in pluripotent stem cells. Science. 2017;356:503-508 pubmed publisher
  89. Evsyukov V, Domanskyi A, Bierhoff H, Gispert S, Mustafa R, Schlaudraff F, et al. Genetic mutations linked to Parkinson's disease differentially control nucleolar activity in pre-symptomatic mouse models. Dis Model Mech. 2017;10:633-643 pubmed publisher
  90. Longo F, Mercatelli D, Novello S, Arcuri L, Brugnoli A, Vincenzi F, et al. Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice. Acta Neuropathol Commun. 2017;5:22 pubmed publisher
  91. Cao M, Wu Y, Ashrafi G, McCartney A, Wheeler H, Bushong E, et al. Parkinson Sac Domain Mutation in Synaptojanin 1 Impairs Clathrin Uncoating at Synapses and Triggers Dystrophic Changes in Dopaminergic Axons. Neuron. 2017;93:882-896.e5 pubmed publisher
  92. Menges S, Minakaki G, Schaefer P, Meixner H, Prots I, Schlötzer Schrehardt U, et al. Alpha-synuclein prevents the formation of spherical mitochondria and apoptosis under oxidative stress. Sci Rep. 2017;7:42942 pubmed publisher
  93. Redmann M, Wani W, Volpicelli Daley L, Darley Usmar V, Zhang J. Trehalose does not improve neuronal survival on exposure to alpha-synuclein pre-formed fibrils. Redox Biol. 2017;11:429-437 pubmed publisher
  94. Song L, McMackin M, Nguyen A, Cortopassi G. Parkin deficiency accelerates consequences of mitochondrial DNA deletions and Parkinsonism. Neurobiol Dis. 2017;100:30-38 pubmed publisher
  95. van der Zee J, Gijselinck I, Van Mossevelde S, Perrone F, Dillen L, Heeman B, et al. TBK1 Mutation Spectrum in an Extended European Patient Cohort with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis. Hum Mutat. 2017;38:297-309 pubmed publisher
  96. Koprich J, Johnston T, Reyes G, Omana V, Brotchie J. Towards a Non-Human Primate Model of Alpha-Synucleinopathy for Development of Therapeutics for Parkinson's Disease: Optimization of AAV1/2 Delivery Parameters to Drive Sustained Expression of Alpha Synuclein and Dopaminergic Degeneration in Macaque. PLoS ONE. 2016;11:e0167235 pubmed publisher
  97. de Oliveira G, Marques M, Cruzeiro Silva C, Cordeiro Y, Schuabb C, Moraes A, et al. Structural basis for the dissociation of ?-synuclein fibrils triggered by pressure perturbation of the hydrophobic core. Sci Rep. 2016;6:37990 pubmed publisher
  98. Kordower J, Goetz C, Chu Y, Halliday G, Nicholson D, Musial T, et al. Robust graft survival and normalized dopaminergic innervation do not obligate recovery in a Parkinson disease patient. Ann Neurol. 2017;81:46-57 pubmed publisher
  99. Sahin C, Lorenzen N, Lemminger L, Christiansen G, Møller I, Vesterager L, et al. Antibodies against the C-terminus of ?-synuclein modulate its fibrillation. Biophys Chem. 2017;220:34-41 pubmed publisher
  100. Zha J, Liu X, Zhu J, Liu S, Lu S, Xu P, et al. A scFv antibody targeting common oligomeric epitope has potential for treating several amyloidoses. Sci Rep. 2016;6:36631 pubmed publisher
  101. Myöhänen T, Norrbacka S, Savolainen M. Prolyl oligopeptidase inhibition attenuates the toxicity of a proteasomal inhibitor, lactacystin, in the alpha-synuclein overexpressing cell culture. Neurosci Lett. 2017;636:83-89 pubmed publisher
  102. Wu Q, Yang X, Zhang Y, Zhang L, Feng L. Chronic mild stress accelerates the progression of Parkinson's disease in A53T ?-synuclein transgenic mice. Exp Neurol. 2016;285:61-71 pubmed publisher
  103. Chai Y, Sierecki E, Tomatis V, Gormal R, Giles N, Morrow I, et al. Munc18-1 is a molecular chaperone for α-synuclein, controlling its self-replicating aggregation. J Cell Biol. 2016;214:705-18 pubmed publisher
  104. Ettle B, Kuhbandner K, Jörg S, Hoffmann A, Winkler J, Linker R. α-Synuclein deficiency promotes neuroinflammation by increasing Th1 cell-mediated immune responses. J Neuroinflammation. 2016;13:201 pubmed publisher
  105. Vingill S, Brockelt D, Lancelin C, Tatenhorst L, Dontcheva G, Preisinger C, et al. Loss of FBXO7 (PARK15) results in reduced proteasome activity and models a parkinsonism-like phenotype in mice. EMBO J. 2016;35:2008-25 pubmed publisher
  106. Mazzulli J, Zunke F, Tsunemi T, Toker N, Jeon S, Burbulla L, et al. Activation of β-Glucocerebrosidase Reduces Pathological α-Synuclein and Restores Lysosomal Function in Parkinson's Patient Midbrain Neurons. J Neurosci. 2016;36:7693-706 pubmed publisher
  107. Cholanians A, Phan A, Ditzel E, Camenisch T, Lau S, Monks T. From the Cover: Arsenic Induces Accumulation of α-Synuclein: Implications for Synucleinopathies and Neurodegeneration. Toxicol Sci. 2016;153:271-81 pubmed publisher
  108. Doucet Beaupré H, Gilbert C, Profes M, Chabrat A, Pacelli C, Giguère N, et al. Lmx1a and Lmx1b regulate mitochondrial functions and survival of adult midbrain dopaminergic neurons. Proc Natl Acad Sci U S A. 2016;113:E4387-96 pubmed publisher
  109. Chen X, Wagener J, Ghribi O, Geiger J. Role of Endolysosomes in Skeletal Muscle Pathology Observed in a Cholesterol-Fed Rabbit Model of Alzheimer's Disease. Front Aging Neurosci. 2016;8:129 pubmed publisher
  110. Gelpi E, Hoftberger R, Graus F, Ling H, Holton J, Dawson T, et al. Neuropathological criteria of anti-IgLON5-related tauopathy. Acta Neuropathol. 2016;132:531-43 pubmed publisher
  111. Baksi S, Tripathi A, Singh N. Alpha-synuclein modulates retinal iron homeostasis by facilitating the uptake of transferrin-bound iron: Implications for visual manifestations of Parkinson's disease. Free Radic Biol Med. 2016;97:292-306 pubmed publisher
  112. Kang W, Chen W, Yang Q, Zhang L, Zhang L, Wang X, et al. Salivary total α-synuclein, oligomeric α-synuclein and SNCA variants in Parkinson's disease patients. Sci Rep. 2016;6:28143 pubmed publisher
  113. Barca E, Kleiner G, Tang G, Ziosi M, Tadesse S, Masliah E, et al. Decreased Coenzyme Q10 Levels in Multiple System Atrophy Cerebellum. J Neuropathol Exp Neurol. 2016;75:663-72 pubmed publisher
  114. Xuan Q, Zhang Y, Liu D, Chan P, Xu S, Cui Y. Post-translational modifications of ?-synuclein contribute to neurodegeneration in the colon of elderly individuals. Mol Med Rep. 2016;13:5077-83 pubmed publisher
  115. Caviness J, Lue L, Hentz J, Schmitz C, Adler C, Shill H, et al. Cortical phosphorylated α-Synuclein levels correlate with brain wave spectra in Parkinson's disease. Mov Disord. 2016;31:1012-9 pubmed publisher
  116. Kawakami I, Kobayashi Z, Arai T, Yokota O, Nonaka T, Aoki N, et al. Chorea as a clinical feature of the basophilic inclusion body disease subtype of fused-in-sarcoma-associated frontotemporal lobar degeneration. Acta Neuropathol Commun. 2016;4:36 pubmed publisher
  117. Sumi Akamaru H, Beck G, Shinzawa K, Kato S, Riku Y, Yoshida M, et al. High expression of ?-synuclein in damaged mitochondria with PLA2G6 dysfunction. Acta Neuropathol Commun. 2016;4:27 pubmed publisher
  118. Ito M, Nakamura K, Mori F, Miki Y, Tanji K, Wakabayashi K. Novel eosinophilic neuronal cytoplasmic inclusions in the external cuneate nucleus of humans. Neuropathology. 2016;36:441-447 pubmed publisher
  119. Kaufmann T, Harrison P, Richardson M, Pinheiro T, Wall M. Intracellular soluble α-synuclein oligomers reduce pyramidal cell excitability. J Physiol. 2016;594:2751-72 pubmed publisher
  120. Duplan E, Giordano C, Checler F, Alves da Costa C. Direct α-synuclein promoter transactivation by the tumor suppressor p53. Mol Neurodegener. 2016;11:13 pubmed publisher
  121. Theillet F, Binolfi A, Bekei B, Martorana A, Rose H, Stuiver M, et al. Structural disorder of monomeric α-synuclein persists in mammalian cells. Nature. 2016;530:45-50 pubmed publisher
  122. Binolfi A, Limatola A, Verzini S, Kosten J, Theillet F, Rose H, et al. Intracellular repair of oxidation-damaged α-synuclein fails to target C-terminal modification sites. Nat Commun. 2016;7:10251 pubmed publisher
  123. Kim C, Ojo Amaize E, Spencer B, Rockenstein E, Mante M, Desplats P, et al. Hypoestoxide reduces neuroinflammation and α-synuclein accumulation in a mouse model of Parkinson's disease. J Neuroinflammation. 2015;12:236 pubmed publisher
  124. Schwab A, Ebert A. Neurite Aggregation and Calcium Dysfunction in iPSC-Derived Sensory Neurons with Parkinson's Disease-Related LRRK2 G2019S Mutation. Stem Cell Reports. 2015;5:1039-1052 pubmed publisher
  125. Ninkina N, Connor Robson N, Ustyugov A, Tarasova T, Shelkovnikova T, Buchman V. A novel resource for studying function and dysfunction of α-synuclein: mouse lines for modulation of endogenous Snca gene expression. Sci Rep. 2015;5:16615 pubmed publisher
  126. Ren Q, Peng M, Dong Y, Zhang Y, Chen M, Yin N, et al. Surgery plus anesthesia induces loss of attention in mice. Front Cell Neurosci. 2015;9:346 pubmed publisher
  127. Parsi S, Smith P, Goupil C, Dorval V, Hébert S. Preclinical Evaluation of miR-15/107 Family Members as Multifactorial Drug Targets for Alzheimer's Disease. Mol Ther Nucleic Acids. 2015;4:e256 pubmed publisher
  128. Xiong R, Zhou W, Siegel D, Kitson R, Freed C, Moody C, et al. A Novel Hsp90 Inhibitor Activates Compensatory Heat Shock Protein Responses and Autophagy and Alleviates Mutant A53T α-Synuclein Toxicity. Mol Pharmacol. 2015;88:1045-54 pubmed publisher
  129. Spencer B, Valera E, Rockenstein E, Trejo Morales M, Adame A, Masliah E. A brain-targeted, modified neurosin (kallikrein-6) reduces α-synuclein accumulation in a mouse model of multiple system atrophy. Mol Neurodegener. 2015;10:48 pubmed publisher
  130. Henstridge C, Jackson R, Kim J, Herrmann A, Wright A, Harris S, et al. Post-mortem brain analyses of the Lothian Birth Cohort 1936: extending lifetime cognitive and brain phenotyping to the level of the synapse. Acta Neuropathol Commun. 2015;3:53 pubmed publisher
  131. Prusiner S, Woerman A, Mordes D, Watts J, Rampersaud R, Berry D, et al. Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism. Proc Natl Acad Sci U S A. 2015;112:E5308-17 pubmed publisher
  132. Dansithong W, Paul S, Scoles D, Pulst S, Huynh D. Generation of SNCA Cell Models Using Zinc Finger Nuclease (ZFN) Technology for Efficient High-Throughput Drug Screening. PLoS ONE. 2015;10:e0136930 pubmed publisher
  133. Bourdenx M, Dovero S, Engeln M, Bido S, Bastide M, Dutheil N, et al. Lack of additive role of ageing in nigrostriatal neurodegeneration triggered by α-synuclein overexpression. Acta Neuropathol Commun. 2015;3:46 pubmed publisher
  134. Zhang L, Shen C, Chu J, Liu Y, Li Y, Zhang L, et al. Icariin reduces α-synuclein over-expression by promoting α-synuclein degradation. Age (Dordr). 2015;37:9811 pubmed publisher
  135. Koch J, Bitow F, Haack J, D Hedouville Z, Zhang J, Tönges L, et al. Alpha-Synuclein affects neurite morphology, autophagy, vesicle transport and axonal degeneration in CNS neurons. Cell Death Dis. 2015;6:e1811 pubmed publisher
  136. Song L, Ma K, Yuan Y, Mu Z, Song X, Niu F, et al. Targeted Overexpression of α-Synuclein by rAAV2/1 Vectors Induces Progressive Nigrostriatal Degeneration and Increases Vulnerability to MPTP in Mouse. PLoS ONE. 2015;10:e0131281 pubmed publisher
  137. Iacono D, Geraci Erck M, Peng H, Rabin M, Kurlan R. Reduced Number of Pigmented Neurons in the Substantia Nigra of Dystonia Patients? Findings from Extensive Neuropathologic, Immunohistochemistry, and Quantitative Analyses. Tremor Other Hyperkinet Mov (N Y). 2015;5: pubmed publisher
  138. Salganik M, Sergeyev V, Shinde V, Meyers C, Gorbatyuk M, Lin J, et al. The loss of glucose-regulated protein 78 (GRP78) during normal aging or from siRNA knockdown augments human alpha-synuclein (α-syn) toxicity to rat nigral neurons. Neurobiol Aging. 2015;36:2213-23 pubmed publisher
  139. Kett L, Stiller B, Bernath M, Tasset I, Blesa J, Jackson Lewis V, et al. α-Synuclein-independent histopathological and motor deficits in mice lacking the endolysosomal Parkinsonism protein Atp13a2. J Neurosci. 2015;35:5724-42 pubmed publisher
  140. Mbefo M, Fares M, Paleologou K, Oueslati A, Yin G, Tenreiro S, et al. Parkinson disease mutant E46K enhances α-synuclein phosphorylation in mammalian cell lines, in yeast, and in vivo. J Biol Chem. 2015;290:9412-27 pubmed publisher
  141. Thomzig A, Wagenführ K, Daus M, Joncic M, Schulz Schaeffer W, Thanheiser M, et al. Decontamination of medical devices from pathological amyloid-?-, tau- and ?-synuclein aggregates. Acta Neuropathol Commun. 2014;2:151 pubmed publisher
  142. Deleglise B, Magnifico S, Duplus E, Vaur P, Soubeyre V, Belle M, et al. β-amyloid induces a dying-back process and remote trans-synaptic alterations in a microfluidic-based reconstructed neuronal network. Acta Neuropathol Commun. 2014;2:145 pubmed publisher
  143. Gispert S, Kurz A, Brehm N, Rau K, Walter M, Riess O, et al. Complexin-1 and Foxp1 Expression Changes Are Novel Brain Effects of Alpha-Synuclein Pathology. Mol Neurobiol. 2015;52:57-63 pubmed publisher
  144. Whitfield D, Vallortigara J, Alghamdi A, Howlett D, Hortobagyi T, Johnson M, et al. Assessment of ZnT3 and PSD95 protein levels in Lewy body dementias and Alzheimer's disease: association with cognitive impairment. Neurobiol Aging. 2014;35:2836-2844 pubmed publisher
  145. Postupna N, Keene C, Latimer C, Sherfield E, Van Gelder R, Ojemann J, et al. Flow cytometry analysis of synaptosomes from post-mortem human brain reveals changes specific to Lewy body and Alzheimer's disease. Lab Invest. 2014;94:1161-72 pubmed publisher
  146. Aldrin Kirk P, Davidsson M, Holmqvist S, Li J, Bjorklund T. Novel AAV-based rat model of forebrain synucleinopathy shows extensive pathologies and progressive loss of cholinergic interneurons. PLoS ONE. 2014;9:e100869 pubmed publisher
  147. Lai Y, Kim S, Varkey J, Lou X, Song J, Diao J, et al. Nonaggregated ?-synuclein influences SNARE-dependent vesicle docking via membrane binding. Biochemistry. 2014;53:3889-96 pubmed publisher
  148. Ambrosi G, Ghezzi C, Sepe S, Milanese C, Payan Gomez C, Bombardieri C, et al. Bioenergetic and proteolytic defects in fibroblasts from patients with sporadic Parkinson's disease. Biochim Biophys Acta. 2014;1842:1385-94 pubmed publisher
  149. Tsika E, Glauser L, Moser R, Fiser A, Daniel G, Sheerin U, et al. Parkinson's disease-linked mutations in VPS35 induce dopaminergic neurodegeneration. Hum Mol Genet. 2014;23:4621-38 pubmed publisher
  150. Dimant H, Zhu L, Kibuuka L, Fan Z, Hyman B, McLean P. Direct visualization of CHIP-mediated degradation of alpha-synuclein in vivo: implications for PD therapeutics. PLoS ONE. 2014;9:e92098 pubmed publisher
  151. Wang X, Kang W, Yang Q, Zhang L, Chen S, Liu J. Using gastrocnemius sEMG and plasma ?-synuclein for the prediction of freezing of gait in Parkinson's disease patients. PLoS ONE. 2014;9:e89353 pubmed publisher
  152. Fan X, Jin W, Lu J, Wang J, Wang Y. Rapid and reversible knockdown of endogenous proteins by peptide-directed lysosomal degradation. Nat Neurosci. 2014;17:471-80 pubmed publisher
  153. Smith B, Santos M, Marshall M, Cantuti Castelvetri L, Lopez Rosas A, Li G, et al. Neuronal inclusions of ?-synuclein contribute to the pathogenesis of Krabbe disease. J Pathol. 2014;232:509-21 pubmed publisher
  154. Reyes J, Rey N, Bousset L, Melki R, Brundin P, Angot E. Alpha-synuclein transfers from neurons to oligodendrocytes. Glia. 2014;62:387-98 pubmed publisher
  155. Gombash S, Manfredsson F, Kemp C, Kuhn N, Fleming S, Egan A, et al. Morphological and behavioral impact of AAV2/5-mediated overexpression of human wildtype alpha-synuclein in the rat nigrostriatal system. PLoS ONE. 2013;8:e81426 pubmed publisher
  156. Hilton D, Stephens M, Kirk L, Edwards P, Potter R, Zajicek J, et al. Accumulation of ?-synuclein in the bowel of patients in the pre-clinical phase of Parkinson's disease. Acta Neuropathol. 2014;127:235-41 pubmed publisher
  157. Hall H, Jewett M, Landeck N, Nilsson N, Schagerlöf U, Leanza G, et al. Characterization of cognitive deficits in rats overexpressing human alpha-synuclein in the ventral tegmental area and medial septum using recombinant adeno-associated viral vectors. PLoS ONE. 2013;8:e64844 pubmed publisher
  158. Scarr E, Dean B. Altered neuronal markers following treatment with mood stabilizer and antipsychotic drugs indicate an increased likelihood of neurotransmitter release. Clin Psychopharmacol Neurosci. 2012;10:25-33 pubmed publisher
  159. Dettmer U, Newman A, Luth E, Bartels T, Selkoe D. In vivo cross-linking reveals principally oligomeric forms of ?-synuclein and ?-synuclein in neurons and non-neural cells. J Biol Chem. 2013;288:6371-85 pubmed publisher
  160. Amschl D, Neddens J, Havas D, Flunkert S, Rabl R, Römer H, et al. Time course and progression of wild type ?-synuclein accumulation in a transgenic mouse model. BMC Neurosci. 2013;14:6 pubmed publisher
  161. Canron M, Perret M, Vital A, Bezard E, Dehay B. Age-dependent ?-synuclein aggregation in the Microcebus murinus lemur primate. Sci Rep. 2012;2:910 pubmed publisher
  162. Gorbatyuk M, Shabashvili A, Chen W, Meyers C, Sullivan L, Salganik M, et al. Glucose regulated protein 78 diminishes ?-synuclein neurotoxicity in a rat model of Parkinson disease. Mol Ther. 2012;20:1327-37 pubmed publisher
  163. Rieker C, Dev K, Lehnhoff K, Barbieri S, Ksiazek I, Kauffmann S, et al. Neuropathology in mice expressing mouse alpha-synuclein. PLoS ONE. 2011;6:e24834 pubmed publisher
  164. Krumova P, Meulmeester E, Garrido M, Tirard M, Hsiao H, Bossis G, et al. Sumoylation inhibits alpha-synuclein aggregation and toxicity. J Cell Biol. 2011;194:49-60 pubmed publisher
  165. Schildknecht S, Pape R, Müller N, Robotta M, Marquardt A, Burkle A, et al. Neuroprotection by minocycline caused by direct and specific scavenging of peroxynitrite. J Biol Chem. 2011;286:4991-5002 pubmed publisher
  166. Feng L, Federoff H, Vicini S, Maguire Zeiss K. Alpha-synuclein mediates alterations in membrane conductance: a potential role for alpha-synuclein oligomers in cell vulnerability. Eur J Neurosci. 2010;32:10-7 pubmed publisher
  167. Fronczek R, Overeem S, Lee S, Hegeman I, van Pelt J, van Duinen S, et al. Hypocretin (orexin) loss in Parkinson's disease. Brain. 2007;130:1577-85 pubmed
  168. Martin L, Liu Z, Chen K, Price A, Pan Y, Swaby J, et al. Motor neuron degeneration in amyotrophic lateral sclerosis mutant superoxide dismutase-1 transgenic mice: mechanisms of mitochondriopathy and cell death. J Comp Neurol. 2007;500:20-46 pubmed